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Natural killer (NK) cells are hematopoietically derived immune cells of the lymphoid 
lineage. Their effector functions, including cytokine secretion and cytotoxicity, are 
controlled by the integration of signals received from both activating and inhibitory 
receptors.  In a phenomenon known as “missing-self” recognition, NK cells eliminate 
self-tissues with aberrantly low or absent MHC class I surface expression, as is common 
in settings of viral infection and transformation, when these cells fail to engage the 
critical NK cell inhibitory receptors. Interestingly, NK cells that develop in an MHC class 
I-deficient environment are defective in natural killing and hyporesponsive to stimulation 
through their activation receptors, rather than hyperactive, as would be predicted by the 
missing-self hypothesis. Through contact between inhibitory receptors and their MHC 
class I ligands, NK cells are rendered both self-tolerant, as well as functionally 
competent. The process of MHC class I-dependent acquisition of NK cell function is 
termed “licensing.” 
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Herein we devised an experimental system of adoptive transfer, where unlicensed, 
splenic NK cells from MHC class I-deficient donors were transferred to wild-type (WT), 
MHC class I-sufficient hosts. Following transfer, donor NK cells expressing an inhibitory 
receptor specific for a cognate host-MHC class I molecule gained function, consistent 
with licensing of these cells. Further work demonstrated that normal MHC class I 
expression is required on both hematopoietic as well as non-hematopoietic tissues in 
order to produce the licensed phenotype. These results indicate that NK-intrinsic 
expression of MHC class I is not required for normal function, leading to the conclusion 
that contacts with MHC class I in the trans orientation are sufficient for licensing. 
Maintenance of the licensed phenotype and the potential for its reversal were examined 
following the inverse adoptive transfer of licensed, splenic WT NK cells into MHC class 
I-deficient hosts. We found that maintenance of the licensed phenotype also requires 
MHC class I expression by both hematopoietic and non-hematopoietic cells, and that loss 
of either of these contacts results in the loss of NK cell function, suggesting that licensing 
is reversible. Additionally, these results demonstrate that contacts with MHC class I 
molecules in the cis orientation are insufficient to maintain the licensed phenotype.  
 
Finally, in a second experimental model, parabiosis of MHC class I-deficient mice to WT 
partners, we explored the effect of bidirectional manipulation of MHC class I expression 
on NK cell function. Unexpectedly, we found a rapid and specific destruction of the 
spleen in the MHC class I-deficient partner, which appears to occur by a mechanism that 
is at least partially NK-dependent. These results suggest that factors not supplied in the 
context of adoptive transfer may contribute to the maintenance of function of WT NK 
 - iv - 
cells, and that the NK-mediated survey of missing-self seems to be restricted to tissues of 
hematopoietic origin. 
 
In summary, these results demonstrate that NK cell licensing is both plastic and dynamic, 
fundamentally unique among the educational processes of immune lymphocytes. These 
results have important implications for the field NK immunotherapy, such as in the 
setting of peripheral NK cell adoptive transfer following bone marrow transplantation.  
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CHAPTER 1: 
Introduction 
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Natural killer cell ontogeny and function 
Natural killer (NK) cells are hematopoietically derived immune cells of the lymphoid 
lineage. Unlike T and B lymphocytes, NK cells are classified as members of the innate 
immune system, along with cells of the myeloid linage, such as macrophages, dendritic 
cells and neutrophils [1]. NK cells are involved in the earliest phases of the immune 
response and have the capacity to execute effector functions without the need for prior 
stimulation, as was first revealed by their intrinsic tumor-killing capacity, earning them 
the name “natural killer” cells [2-4]. Intact NK cell effector functions are critical for a 
successful antiviral response [5-8], and these effector functions include both the ability to 
secrete immunomodulatory cytokines, such as interferon-gamma (IFNγ) and interleukin-
12 (IL-12), as well as direct cytolytic function, via perforin and granzyme activity [9].  
Importantly, natural killer cells do not express a single rearranged antigen-specific 
receptor, like T and B lymphocytes, but instead rely on the integration of signals from 
both activating and inhibitory invariant receptors for proper function. 
 
Activating NK cell receptors and their ligands 
Activating receptors on NK cells are structurally diverse and fall into two main 
categories: 1) the type II C-type lectin-like proteins, including the NKG2C:CD94 
heterodimer and NKG2D homodimer expressed on both murine and human NK cells, as 
well as members of the Ly49 family of receptors in mice, notably Ly49D and Ly49H 
[10], and 2) the type I immunoglobulin super family (IgSF) proteins, including the 
natural cytotoxicity receptors (NCRs), such as NKp30 and NKp44 in humans and NKp46 
in both humans and mice, as well as some members of the family of killer 
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immunoglobulin receptors (KIR) in humans. Although the ligand-binding domains of NK 
cell activating receptors are structurally varied, these receptors share other features in 
common, including a positively charged amino acid residue in the transmembrane region 
and a short cytoplasmic tail [11]. This truncated cytoplasmic domain renders activating 
receptors incapable of intrinsic signal transduction. However, the charged transmembrane 
amino acid allows for non-covalent association with other transmembrane adaptor 
proteins that do possess intrinsic signaling capacity, such as such as DAP12 (DNAX-
associated protein of 12kDa, also known as KARAP), FcεRγI (commonly referred to as 
FcRγ), and CD3ζ [12, 13]. 
 
Ligands recognized by NK cell activating receptors are even more diverse than the 
receptors themselves (Table 1). They include self-derived proteins, for example the MHC 
Ib (major histocompatibility complex, class Ib) molecules Qa-1 and HLA-E, expressed in 
mice and humans respectively, which engage NKG2C:CD94 [10]. Additionally, the 
activating receptor NKG2D may be engaged via another class of ligands termed 
“induced-self” proteins, molecules not typically expressed on healthy cells but 
upregulated on unhealthy cells following viral infection or genetic transformation [14-
16]. Examples include: H60, Mult-1 and the Rae-1 family members in mice, and 
MICA/MICB as well as the ULBP proteins in humans [17]. Some NK cell activating 
receptors are engaged by exogenous ligands, such as virally encoded proteins like viral 
hemagglutinin, directly recognized by NKp46 [18], and m157, recognized by Ly49H [6]. 
As can be seen, NK cells possess multiple activating receptors to sense pathogenic insult 
and initiate response. 
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Upon ligand binding by an activating NK cell receptor, the associated adaptor proteins, 
composed of two disulfide-linked signaling chains each containing a canonical ITAM 
(immunoreceptor tyrosine-based activation motif, D/ExxYxxL/Ix6-8YxxL/I) in the 
cytoplasmic domain, initiate signal transduction. Both tyrosine residues in the ITAMs 
become phosphorylated by Src-family protein tyrosine kinases, allowing for the 
recruitment and binding of Syk-family protein tyrosine kinases, such as Syk and Zap70 
[19], to the phospho-ITAM sequences. Binding of Syk-family members allows for 
phosphorylation of downstream effector molecules, such as PI(3)K (phosphoinositol-3 
kinase), LAT (linker of activated T cells), and PLCγ (phospholipase Cγ), resulting in 
activation of the calcium signaling pathway and downstream effectors of the MAP kinase 
pathway, activating transcription factors such as NF-κB [13], and culminating in 
initiation of NK cell effector functions, such as cytokine production and degranulation. 
 
Inhibitory NK cell receptors and their ligands 
Inhibitory NK cell receptors, like activating NK cell receptors, can generally be classified 
into one of two structural groups: 1) the type II C-type lectin-like proteins, including the 
homodimeric murine Ly49 receptors, as well as the NKG2A:CD94 heterodimer, 
expressed in both mouse and human, and 2) type I IgSF members, such as the KIRs 
expressed in humans. Unlike activating NK receptors, the inhibitory NK receptors do not 
possess charged transmembrane residues for association with signaling adapter 
molecules. Instead, each inhibitory receptor is endowed with a long cytoplasmic tail, 
capable of intrinsic signal transduction [13]. 
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Ligands for inhibitory NK cell receptors are less varied than the ligands for activating 
receptors, most being classical MHC I (major histocompatibility complex, class Ia) 
molecules (Table 1). The classical MHC I molecules are recognized by members of the 
Ly49 family in mice and the KIR2DL and KIR3DL proteins in humans. Qa-1 and HLA-
E, β2m-associated, non-classical MHC Ib molecules, are recognized by the 
CD94:NKG2A heterodimer in both species [20]. NK cells also express inhibitory 
receptors specific for other, non-MHC ligands [21], such as E-cadherin bound by KLRG1 
[22, 23], although the significance of these interactions is less well understood. 
 
NK cell inhibitory receptor signaling serves to counteract signals received through 
activating receptors. Each inhibitory receptor encodes a long cytoplasmic tail containing 
an intrinsic ITIM (immunoreceptor tyrosine-based inhibitory motif, I/L/V/SxYxxL/V) 
[13]. Ligation of inhibitory receptors leads to phosphorylation of the ITIM-tyrosine and 
subsequent recruitment and binding of phosphatase molecules, such as SHP-1 (SH2-
containing protein tyrosine phosphatase-1), SHP-2 and SHIP (SH2-containing inositol 
phosphatase) [24, 25]. It is believed that these phosphatases then dephosphorylate 
activating signaling molecules, resulting in termination of the signaling cascade and 
inhibition of NK cell effector function. However, more recent theories of NK cell 
inactivation propose a role for these phosphatases in the prevention of actin cytoskeleton 
reorganization, thereby preventing clustering of activating receptors and initiation of 
downstream signaling events [26]. In any case, it is clear that engagement of inhibitory 
receptors recruits phosphatase molecules, which ‘counterbalance’ activating signaling, 
and serve to inhibit the initiation of NK cell effector function. 
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MHC I engagement and the theory of ‘missing-self’ recognition 
The most familiar function of inhibitory ligand recognition by NK cells is that of 
‘missing-self recognition’ (Figure 1) [27, 28]. NK cells provide defense against 
pathogenic insult and abnormal cell growth by assessing the surface of self-tissues for the 
full complement of MHC I expression. Virally infected or transformed tumorogenic cells 
display antigens through MHC I for presentation to CD8+ T cells. However, in an 
immune evasion strategy, many viruses have developed proteins to block efficient 
antigen processing, peptide loading and subsequent display of MHC I at the cell surface 
[29]. Similarly, tumors are often found to have accumulated mutations that interfere with 
display of antigens through the MHC I antigen-processing pathway [30]. Cells lacking 
surface MHC I fail to engage the critical NK cell inhibitory receptors, inciting anti-viral 
and anti-tumor NK cell function in the form of cytokine secretion and direct cytotoxic 
activity. It has been definitively demonstrated that engagement of an inhibitory receptor 
with its cognate MHC I ligand is the interaction responsible for the inhibition of NK cell 
lytic activity, providing a molecular basis for ‘missing-self’ recognition [31, 32].  
 
Necessary role for MHC I in NK cell function 
One might predict that NK cells isolated from mice deficient in the expression of MHC I 
molecules would be hyper-responsive, due to the absence of inhibitory receptor 
engagement. Using the strategy of targeted gene-deficiency (i.e. ‘knockout’) to delete 
genes encoding proteins necessary for MHC I expression, such as β2-microglobulin (β2m) 
and TAP (transporter of antigenic peptides), this hypothesis was tested. Unexpectedly, 
NK cells isolated from environments lacking MHC I were found to be defective in 
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natural cytotoxicity and hyporesponsive to activation through crosslinking of activating 
receptors [33-35].  Later studies confirmed that NK cells from humans with similar 
genetic deficiencies (defects in HLA [human leukocyte antigen] expression) demonstrate 
identical functional deficits [36]. 
 
For a number of years, the basis for poor NK cell function in MHC I-deficient hosts 
remained unclear. At the time these data were published, identities of NK cell activating 
and inhibitory receptors and their ligands were still being deciphered. One idea, known 
informally as the ‘at least one’ theory, proposed that NK cells in MHC I-deficient mice 
(and humans) remained self-tolerant, even in the apparent absence of interaction with an 
inhibitory MHC I molecule, through undetected interactions between (undiscovered) 
inhibitory receptors and ligands [37-39]. However, this theory was refuted when 
experiments revealed the presence of NK cells lacking inhibitory receptors specific for 
any of the expressed self-MHC alleles, in hosts with normal MHC I expression [40]. 
Importantly, not only were these NK cells self-tolerant, they were shown to have defects 
in functional capacity. Thus, it was determined that the presence of MHC I alone is 
insufficient for the generation of functional NK cells. Instead, normal NK cell function 
appeared to require the ability of an NK cell to specifically recognize self-MHC I. 
 
NK cell licensing 
More recently, the contribution of MHC I to the development and function of NK cells 
was examined in greater detail on a single cell level. Utilizing a cell-free stimulation 
assay, Kim et al. determined that the signaling defect in NK cells derived from MHC I-
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deficient hosts is widespread, impacting activation through multiple receptors that 
associate with various signaling adaptor molecules, indicating a generalized deficiency in 
the reception of activating signals [41]. However, they show that cells remain responsive 
to chemical stimuli, demonstrating that downstream effectors of the activating signaling 
pathways remain intact.  
 
The authors further demonstrate that transfection of primary cells with a self MHC-
specific inhibitory receptor and subsequent exposure of these cells to the ligand improved 
their ability to produce cytokines in response to crosslinking of activating receptors. 
Furthermore, in order for the NK cells to gain function, it was demonstrated that the 
transfected inhibitory receptor must contain an intact ITIM domain. This result was 
particularly intriguing, as there is not great precedent for the transduction of a positive 
signal (i.e. gain of function) through a receptor that is believed to have a purely inhibitory 
function. The observed phenomenon was termed ‘licensing’ and is defined as the process 
whereby the interaction of an inhibitory receptor with a cognate self-MHC ligand confers 
capacity for full biological function in a mature NK cell (Figure 2).  
 
Similar education effects have been observed for human NK cells via self-HLA 
recognition by killer immunoglobulin-like receptors (KIRs), receptors related by 
convergent evolution to murine Ly49 receptors [42-45]. Thus, self-MHC I engagement 
by NK cell inhibitory receptors appears to be a fundamental element in acquisition of NK 
cell effector function 
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Proposed mechanisms for licensing 
The nature of the signal responsible for NK cell licensing remains unclear. There are two 
contrasting models to describe the mechanism of the gain of function induced by 
licensing: disarming and arming [46]. In the model of disarming, the signal delivered to 
the NK cell through the inhibitory receptor is of an inhibitory nature, consistent with the 
function of an ITIM-bearing Ly49 receptor in a mature cell. This signal serves to 
counteract some continuous signal received via engagement of an activating receptor 
with a self-ligand. The transmission of an inhibitory signal via recognition of self-MHC I 
by an inhibitory NK receptor is postulated to alleviate or balance the positive signal and 
rescue the NK cell from overstimulation. NK cells devoid of inhibitory receptors or 
unable to interact functionally with inhibitory ligands, as in the case of MHC I-deficient 
animals, receive only positive signals, resulting in the induction of anergy. The nature, 
identity and source of the endogenous activating ligands and receptors responsible for 
induction of positive signaling have not been identified.  
 
In contrast to the theory of disarming is that of arming, in which recognition of self-MHC 
I by an inhibitory NK cell receptor results in transmission of a ‘positive’ signal, resulting 
in functional responsiveness.  In the absence of this licensing signal, NK cells remain 
hyporesponsive. While this theory, transmission of a positive signal through a receptor 
traditionally classified as having only inhibitory function, may be difficult to 
conceptualize, it should be noted that receptors often possess the capacity to signal 
multiple functions, depending on context. For example, the major antigen receptor of the 
T cell (TCR), serves to activate T cell effector functions, but may also transmit signals 
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resulting in anergy or commitment to a regulatory lineage, rather than activation [47]. 
Regardless of which mechanism is correct, it is clear that the interaction of an inhibitory 
NK cell receptor with a self-MHC ligand is required for the generation of fully competent 
mature NK cells. 
 
Licensing as a rheostat 
Thus far, licensing has been presented as an all or none phenomenon. However, under the 
tuning or rheostat model, NK cells acquire function in a graded manner depending on the 
number of inhibitory receptor:self-MHC interactions [48]. When NK cells possess more 
inhibitory receptors capable of interacting with multiple alleles of MHC I, they show 
greater function following stimulation through their activating receptors. NK cells with 
fewer self-MHC I contacts are less responsive.  In studies using mice with different 
numbers of MHC alleles [49], increased function of NK cells was observed in hosts 
expressing multiple MHC I alleles, indicating a positive correlation between expression 
of MHC I alleles and education or licensing of the NK cell population. Additionally, in 
studies using multicolor flow cytometry to identify NK cell populations expressing 
multiple, single or no inhibitory receptors for self-MHC I molecules, there was a similar 
effect: NK cells with more inhibitory receptors capable of binding host MHC I molecules 
displayed greater function [50, 51]. Therefore, it has been confirmed that there is a 
positive correlation between the number of inhibitory receptors contacting self-MHC and 
increased NK cell function. 
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Kinetics, maintenance and reversibility of licensing  
While the importance of the interaction between inhibitory receptor and self-ligand is 
understood, many other details of NK cell licensing remain unclear. In particular, 
questions remain regarding the time required for licensing to occur and the location of its 
occurrence, the relationship of licensing to development, the nature of the intracellular 
signaling events transmitted via the inhibitory receptor, and whether licensing results in a 
permanent alteration of NK cell function, akin to lineage commitment, or whether it is 
mutable.  
 
One interesting unexplored topic is the relationship of NK cell licensing to the 
development of NK cells. During development in the bone marrow, NK cells undergo a 
proliferative burst following Ly49 receptor expression [52]. One may hypothesize that 
the signal resulting in this proliferation is somehow related to the licensing of NK cells, 
as both processes seem dependent upon the interaction of Ly49 receptors with self MHC. 
Additional literature reports suggest a possible survival advantage for NK cells following 
the interaction of inhibitory Ly49 receptors with self MHC molecules [53], again 
implying a positive relationship between NK cell development and licensing. While these 
data suggest that licensing may be a developmental process, occurring in the bone 
marrow, the timing and localization of NK cell licensing have not been formally 
established. 
 
Another unresolved issue pertaining to both licensing and development concerns the 
permanency and plasticity of licensing. In particular, it is unknown whether licensing of 
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NK cells results in a permanent alteration of their phenotype, akin to lineage 
commitment, or whether the phenotype is reversible, allowing a previously licensed cell 
to become unlicensed. Additionally, it is unknown whether the specificity of licensing 
may be altered, such that an NK cell could become ‘relicensed’ on a different set of MHC 
I alleles. 
 
Contributions of this work 
In this thesis work, we address some of these questions using an experimental system of 
adoptive transfer of mature MHC I-deficient NK cells, which results in the inducible 
licensing of transferred NK cells. Characteristics examined include responsiveness to 
crosslinking of activating receptors, ability to efficiently kill target cells, and surface 
phenotype. Later experiments address several central issues regarding licensing, 
including its kinetics, the factors required for its induction and maintenance, as well as 
the potential for reversal of the licensed phenotype. Implications of these results on the 
therapeutic use of human NK cells will be discussed. 
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Table 1. Natural killer cell activating and inhibitory receptors and their ligands. 
Natural killer cell function is dictated by an integration of signals through activating and 
inhibitory receptors. Listed are common activating and inhibitory NK cell receptors and 
their ligands. Receptors are expressed by both mouse and human, unless otherwise 
indicated. 
 - 14 - 
 
 - 15 - 
 
 
 
 
 
 
 
Figure 1. ‘Missing-self’ recognition results in NK cell activation.  
NK cell function is dictated by an integration of signals through activating and inhibitory 
receptors. Left: Infected or transformed cell does not express surface MHC I (‘missing-
self’), and may or may not express activating ligands. NK cell effector functions of 
cytotoxicity and cytokine secretion are induced. Center: Healthy target cell expresses 
MHC I, inhibiting NK cell activation. Right: Infected or transformed cell expresses MHC 
I and viral or ‘induced-self’ proteins (e.g. H60, Mult-1). NK cell may become activated if 
a high number of activating receptors are also engaged.  
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Figure 2. NK cell licensing results in functional competence and self-tolerance. 
NK cells become licensed following interaction of an inhibitory NK receptor with a 
proper self-MHC I ligand. NK cells that are licensed are functionally competent to 
respond to stimulation via activating receptor crosslinking, and remain self-tolerant as a 
result of continued interaction between the inhibitory receptor and self-MHC I. 
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Mice 
C57BL/6 and C57BL/6 Ly5.1 mice were purchased from the National Cancer Institute 
(Frederick, MD) and The Jackson Laboratory (Bar Harbor, ME). β2-microglobulin-/- mice 
were purchased from The Jackson Laboratory. β2m-/- Ly5.1 mice were generated in house 
by crossing β2m-/- mice with C57BL/6 Ly5.1 mice.  H2Kb-/- H2Db-/- H2Dd-expressing 
mice (KODO D8) were generated by crossing H2Kb-/- H2Db-/- mice (purchased from 
Taconic Farms, Germantown, NY) with mice expressing a Dd transgene (D8), provided 
by D. Marguiles (National Institute of Allergy and Infectious Diseases, Bethesda, MD).  
Triple knock-out (TKO) Kb-/-Db-/-β2m-/- mice with transgenic expression of Kb-OVA 
MHC I as a single protein (TKO SCT-Kb Tg mice) were the generous gift of Dr. Ted 
Hansen (Washington University, Saint Louis, MO) [54]. Jinx mice, harboring a mutation 
in Unc13d, were kindly provided by Dr. Bruce Beutler (Scripps Research Institute, La 
Jolla, CA) and have been previously described [55].  Animals were housed in specific-
pathogen free facilities at Washington University, and all mice were used between 6 – 16 
weeks of age. Experiments were conducted in accordance with the animal protocol 
approved by the Animal Studies Committee at Washington University. 
 
Antibodies, surface staining and flow cytometry 
The following antibodies and reagents were purchased from BD Biosciences (San Jose, 
CA): anti-CD3 (145-2C11), anti-Ly5.1 (A20), anti-Ly5.2 (104), anti-NK1.1 (PK136), 
anti-Ly49A (JR9 and A1), anti-CD69 (H1.2F3), streptavadin APC (SA-APC), SA-
PerCP-Cy5.5, SA-PE-Cy7. The following antibodies were purchased from eBioscience 
(San Diego, CA): anti-NKp46 (29A1.4), anti-IFNγ (XMG1.2), anti-KbOVA (eBio25-
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D1.16), anti-CD94 (18d3), anti-NKG2D (CX5), anti-CD11b (M1/70), anti-CD127 
(A7R34), anti-CD49 (DX5), anti-CD107a (eBio1D4B). Anti-Ly49C (4LO33) and anti-
Ly49H (3D10) were purified in our laboratory from hybridoma supernatants.  (The 
4LO33 hybridoma was provided by Suzanne Lemieux, Institut National de la Recherche 
Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada.) All surface staining was 
performed on ice in staining buffer (3% FCS, 0.1% NaN3 in PBS) containing anti-FcR 
antibodies (2.4G2). Samples were collected on a FACSCanto (Becton Dickinson, 
Franklin Lakes, NJ) using FACSDiva software (Becton Dickinson) and data were 
analyzed using FlowJo (TreeStar, Ashland, OR). 
 
CFSE-label and adoptive transfer 
For adoptive transfer experiments, donor splenocytes were purified by homogenization of 
spleens through a 70µM nylon filter. These cell preparations were red-blood cell lysed 
(10mM KHCO3, 150mM NH4Cl, 0.1mM EDTA pH 8.0) for 5min at RT and washed with 
media. Cells were resuspended in PBS, counted and washed, removing an aliquot to later 
determine NK percentage via antibody staining and flow cytometry. Cells were 
resuspended at 1×108 cells/mL in a 1µM CFSE (carboxyfluorescein diacetate 
succinimidyl ester, CellTrace™ Invitrogen) solution, and incubated at RT for 15min in 
the dark. Cells were washed twice in PBS and resuspended at 2.5×108 splenocytes/mL, 
and a small aliquot removed to verify the CFSE label via flow cytometry. Using a 28g 
insulin syringe, 200uL of the cell suspension was injected into the lateral tail vein of age-
matched, sex-matched recipient mice.  
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In vitro stimulation and intracellular cytokine staining (‘licensing assay’) 
Splenocytes were harvested from adoptive transfer recipients at day 7 post-transfer and 
stimulated with anti-NK1.1 (or anti-Ly49H) mAb as previously described [41]. Briefly, 
1.0 ×107 splenocytes were plated into 6-well plates, that were either precoated with 
antibody (5µg/mL, 1.5 h at 37°C), contained media alone, or contained media with 0.5µg 
phorbol myristate acetate (Sigma, St. Louis, MO) and 4µg ionomycin (Calbiochem, La 
Jolla, CA). Cells were incubated for 1 h at 37°C in 5% CO2. BrefeldinA (GolgiPlug, BD 
Biosciences) was added and cells were incubated for an additional 7h. Cells were then 
fixed and permeabilized (Cytofix/Cytoperm, BD Biosciences), followed by antibody 
staining for intracellular IFNγ, as previously described [41]. 
 
Degranulation assay 
Splenocytes were harvested from adoptive-transfer recipients at day 7 post-transfer, and 
NK cells were purified using magnetic separation columns (MACS NK isolation kit, 
Miltenyi Biotech, Germany). Separation purity was determined via flow cytometry 
(gating on CD3- NK1.1+ cells), and NK cells were plated with target cells at a ratio of 1:1 
(E:T) in 96-well V-bottom plates. Anti-CD107a antibody and monensin (eBioscience) 
were added to each well prior to incubation. Plates were incubated for 2 hours at 37°C, 
after which surface staining for flow cytometry was performed as described above. 
 
Co-culture and kinetic analyses 
Freshly isolated RBC-lysed splenocytes from C57BL/6 Ly5.1 and β2m-/- donors were 
plated in 6-well plates at ratios indicated in the figures, at 1.0×107 cells/mL of R10 media 
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(RPMI, 10%FCS, L-glutamine, pen-strep)/well. For the kinetic analysis, a single donor 
population was prepared and injected into multiple recipients, which were analyzed on 
different days following transfer using the same set of reagents.  
 
In vivo cytotoxicity assay 
Splenocytes were harvested from WT and β2m-/- donors by homogenization of spleens 
through 70µM nylon mesh. Cell preparations were RBC lysed and differentially labeled 
with 1µM or 2µM CFSE for 15min at RT, after which time cells were washed and 
resuspended at 1.5×108 cells/mL. A small aliquot was removed from each to verify the 
CFSE label by flow cytometry. 100µL of each cell preparation was taken, mixed and 
drawn into a 28-gage syringe, and injected into the lateral tail vein of age-matched, sex-
matched recipients (resulting in a final injection of 1.5×107 WT cells and 1.5×107 β2m-/- 
cells in a total volume of 200µL). 16hr post-transfer, recipient mice were sacrificed and 
spleens were homogenized and analyzed by flow cytometry for the presence of target 
cells remaining. The ratio of β2m-/-:WT targets recovered was determined. 
 
Generation of bone marrow chimeras 
The day of transfer, recipient mice were lethally irradiated (950rad). Using sterile 
technique, donor bone marrow was harvested by flushing femurs and tibias with a 
solution of 2% FCS in HBSS. Cells from multiple donors were pooled, washed and 
resuspended in RBC-lysis buffer for 5min at RT. Samples were washed with PBS, 
counted and resuspended at 1×107 cells/mL. Recipient mice were injected with 2×106 
donor cells, via injection of the lateral tail vein. Mice were maintained on antibiotic 
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drinking water (sulfamethoxazole/trimethoprim, Hi-Tech Pharmacal Co, Inc, Amityville, 
NY) for 3w post-irradiation. 
 
Generation of parabiotic mice 
Mice were co-housed for 1w before SX, and opposing lateral sides were shaved 1d before 
the procedure. Mice were anesthetized with 5% isofluorane (1 – 1.5 L/min O2), and 
maintained on isofluorane (2%) for the entire procedure. Using sterile tools and within a 
sterile field, skin was sterilized with betadine and an incision was made just distal to the 
patella. The incision was lengthened along the lateral aspect, continuing to the scapula 
and diverting along the brachial line, stopping just distal to the elbow. A margin of skin 
(~0.5cm) was separated away from the underlying connective tissue along the length of 
the incision, taking care to avoid puncture or compromise of the peritoneal cavity. 
Periodically through the procedure, the exposed mucosal layer was moistened with sterile 
saline solution. A single suture (chromic gut, Ethicon UG-203) was tied around the 
proximal head of the tibia, and another tied around the radius of the forearm. Mice were 
then placed in proximity and a single continuous suture was used to join the patellar 
ligament. The free ends of individual sutures from the tibia of each mouse were joined. 
This was repeated with the sutures of the radius. Skin was approximated and the incision 
was closed with 15-20 stainless steel wound clips (9mm, Beckton Dickinson, Autoclip®). 
Each mouse was injected with 0.1cc buprenorphine (0.02mg/mL) for pain management, 
and 1000cc 5% glucose in saline, for rehydration. Pairs were warmed under a heat lamp 
until mobile, then returned to standard cages, where a gel nutrition supplement, Clear 
H2O Hydrogel® (Portland, Maine), was placed on the bottom of the cage to facilitate 
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access. Pain medication was given for 3d post-SX, tapered from 0.1cc to 0.05cc. 
Antibiotics (trimethoprim/sulfamethoxazole) were administered via drinking water from 
the day of surgery through sacrifice. 
 
Statistical analysis 
Data are presented as mean ± SD. Statistics were generated using unpaired Student’s t 
test within GraphPad Prism software (GraphPad, La Jolla, CA), and values p < 0.05 were 
considered significant. 
  
 
 
 
 
 
 
 
CHAPTER 3: 
Characterization of newly licensed NK cells 
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The goal of this thesis work is to determine factors that contribute to the MHC I-
dependent gain of function, or licensing, of natural killer (NK) cells, as well as factors 
contributing to the maintenance of the licensed phenotype and the potential for its 
reversal. To more fully understand the processes surrounding licensing, as well as the 
potential for normal function in MHC I-deficient NK cells, we chose to utilize a system 
of adoptive transfer of MHC I-deficient NK cells to MHC I-sufficient hosts. Preliminary 
findings demonstrated that adoptive transfer of mature, peripheral, MHC I-deficient NK 
cells to wild type (WT) hosts led to increased capacity for cytokine production by 
previously hyporesponsive donor cells. We hypothesized that the gain of function is due 
to licensing of these cells, induced by exposure to host MHC I. We therefore sought to 
further investigate the gain of function, as we believed these findings would provide 
insight regarding the natural processes of NK cell licensing. 
 
Introduction 
A connection between MHC I expression and the generation of functional NK cells has 
been appreciated for nearly 20 years [33-35]. However, many of the details regarding the 
exact role for MHC I in NK cell education have remained poorly understood. Previous 
attempts to further characterize the contribution of MHC I to NK cell development and 
acquisition of function relied heavily on chimeric mice, in which the hematopoietic 
system of an irradiated host is reconstituted with the bone marrow from a genetically 
different donor [28, 33, 56, 57]. Results from these studies indicated that NK cells arising 
from MHC I-deficient bone marrow within a WT host (and vice versa) do not gain full 
functional capacity, as measured by a reduction in the in vivo rejection of MHC I-
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deficient bone marrow or ex vivo killing of target cells. Interestingly, mixed bone marrow 
chimeras (WT+β2m-/- marrow  WT hosts), yielded an intermediate killing phenotype. 
An important caveat to these experiments is that functional analysis (typically capacity 
for target rejection) was assessed for the bulk NK cell population. Therefore, the 
observed intermediate phenotype could not be definitively ascribed to full function of one 
subset and null function of the other, and/or equivalently intermediate function of some 
or all cells in the population. Thus, previous data utilizing bone marrow chimera systems 
to probe the influence of MHC I molecules on NK cell acquisition of function remained 
incomplete. 
 
While experimental methods traditionally used to study NK cell biology had not yielded 
satisfying answers regarding the contribution of MHC I to NK cell development and 
function, important advances in experimental technique, including a cell-free stimulation 
assay (the ‘licensing assay’) [41] have allowed for progress in the field. In this particular 
assay, plate-bound monoclonal antibody with specificity for an activating NK cell 
receptor is used to crosslink the receptor, thereby stimulating cytokine production by NK 
cells during ex vivo culture. An inhibitor of the Golgi apparatus (BrefeldinA) [58] is 
added to the cultures, to allow for intracellular accumulation of cytokines, in particular 
IFNγ. The NK cells are then assayed for IFNγ production via intracellular staining and 
flow cytometry. Thus, cytokine production (i.e. functional capacity) can definitively be 
determined for each individual NK cell. 
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In our experiments, adoptive transfer of labeled cells followed by intracellular cytokine 
staining and analysis via flow cytometry permits direct comparison of IFNγ production 
between donor-derived NK cells and endogenous host NK cells, allowing for a 
quantitative assessment of the influence of host environment on donor cell function. 
Therefore, when paired with analyses of function at the single-cell level as in our 
experimental system, adoptive transfer becomes a useful tool with which to determine the 
contribution of MHC I to NK cell development and function.  
 
NK cell adoptive transfer protocol 
Briefly, the details of adoptive transfer are as follows: spleens are harvested from donor 
mice and splenocytes recovered from disrupted organs. Next, the splenocytes are treated 
with CFSE (carboxyfluorescein succinimidyl ester), a fluorescent dye that covalently 
labels cell membranes [59]. The cells are then washed, counted and aliquoted for i.v. 
injection into recipient mice. Typically, recipients were sacrificed 7 days post-injection, 
upon which time spleens were harvested, yielding a mixture of host- and donor-derived 
splenocytes, which were then experimentally manipulated. 
 
Validation and optimization of adoptive transfer system 
Initially, transfers of WT NK cells to WT hosts were performed, in order to optimize the 
experimental system, as well as examine the potential for artifact. Cells were injected into 
WT, immunoreplete hosts, which were not pre-conditioned (e.g. irradiation or NK-
depletion) prior to injection. Upon harvest of host spleens 7d post-adoptive transfer (AT), 
the phenotype of host and donor splenocytes was examined by flow cytometry, paying 
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close attention to markers indicative of an activated NK cell phenotype. The phenotype of 
WT donor NK cells was equivalent to that of resting, WT host NK cells, indicating that 
donor cells are not activated by purification and adoptive transfer (Figure 3a). 
Additionally, WT NK cells did not proliferate in the WT hosts, (Figure 3b), as there was 
no dilution of CFSE, further demonstrating that adoptive transfer of NK cells did not 
initiate NK cell activation. 
 
To maximize the number of donor NK cells recovered, we experimented with increasing 
the number of splenocytes transferred, from 5×107 up to ~8×107 (containing ~1.6×106 
NK cells). However, increasing the number of transferred cells did not result in a greater 
recovery of donor NK cells from immunoreplete hosts. At 7d post-transfer, the average 
yield was consistently around 2×105 donor NK cells, comprising ~10% of the NK cell 
population in the recipient spleen. As we wished to recover the maximum number of 
donor cells possible, we next examined the potential for the use of immunodeficient mice 
as adoptive transfer recipients. We utilized doubly deficient Rag2-/-γC-/- mice, which lack 
T, B and NK cells [60]. At 7d post-AT, WT donor NK cells recovered from Rag2-/-γC-/- 
hosts had increased surface expression of activation markers, including: CD11b (Mac-1), 
CD11c and CD69 (Figure 4a). Additionally, the donor cells had proliferated to a great 
extent (Figure 4b). Taken together, these results strongly suggest that the WT donor NK 
cells had become activated in the immunodeficient hosts. These results were not 
particularly surprising, as other studies have noted the activating effects of homeostatic 
proliferation upon lymphocytes, in particular NK cells [61]. Therefore, while the use of 
immunoreplete hosts does limit the number of donor cells that may be recovered, in order 
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to avoid complications in data interpretation associated with activation of cells following 
homeostatic proliferation, we opted to use only immunoreplete hosts for the remainder of 
our studies. 
 
WT NK-mediated rejection of MHC I-deficient splenocytes can be overwhelmed 
In order to study the effect of MHC I on NK cell development and function, we wished to 
transfer MHC I-deficient splenocytes to WT hosts. It was considered that MHC I-
deficient cells, such as those from β2m-/- mice, would not successfully engraft in WT 
hosts, as it is known that MHC I-deficient grafts are eliminated following transfer to WT 
mice, in an NK-dependent manner [28, 33]. However, transfer of a sufficiently large 
number of cells can result in graft acceptance [62, 63], and we suspected we could 
produce a similar result. In order to verify this, we titrated down the number of MHC I-
deficient splenocytes transferred to WT hosts, and found that grafts of fewer than 3×107 
cells were efficiently eliminated. Additionally, we compared the survival of various 
MHC I-deficient immune cell subsets (e.g. T, B and NK) following their transfer to WT 
hosts, and found all populations engrafted/were eliminated equivalently. We therefore 
concluded that within the experimental time frame of 7d, transfer of a sufficient number 
of MHC I-deficient cells can, in fact, overwhelm the ability of endogenous WT NK cells 
to eliminate the MHC I-deficient graft, in a general mechanism that does not appear to 
favor retention of any hematopoietic lineage over another.  
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MHC I-deficient NK cells acquire the ability to make IFNγ  following adoptive  
transfer to MHC I+ hosts 
To examine the potential for gain of function by hyporesponsive, peripheral MHC class I-
deficient NK cells, we harvested β2m-/- splenocytes, CFSE-labeled them and injected 
them into MHC I-sufficient WT or control β2m-/- hosts. At day 7, host spleens were 
harvested and bulk splenocytes were activated in vitro by anti-NK1.1 crosslinking, then 
analyzed for IFNγ production, via intracellular flow cytometry (i.e. the ‘licensing assay’). 
Surprisingly, we found that following activating receptor crosslinking, donor-derived 
MHC I-deficient β2m-/- NK cells recovered from WT hosts produced IFNγ at a level 
equivalent to that of host WT NK cells (Fig 5). In contrast, β2m-/- donor cells recovered 
from β2m-/- control hosts produced IFNγ at a frequency identical to host-derived β2m-/- 
NK cells (Fig 5). This was equivalent to the hyporesponsive production of IFNγ by NK 
cells from unmanipulated β2m-/- control animals (data not shown). Additionally, this 
greater capacity for cytokine production was also observed when NK cells were 
stimulated through another activating receptor, Ly49H, which uses a different 
intracellular signaling chain (DAP12, as opposed to FCRγ, used by NK1.1, [64]) (Figure 
6). Therefore, adoptive transfer of hyporesponsive, MHC I-deficient splenic NK cells 
appeared to result in the acquisition of global activation receptor-associated responses 
that correlated with host NK cell responsiveness. 
 
Using intracellular staining and flow cytometry, we also examined the NK cell 
production of cytokines other than IFNγ, including TNFα and GM-CSF, following 
adoptive transfer. However, our stimulation to assess the licensed phenotype, cross-
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linking of activating receptors, does not induce NK cells to produce large quantities of 
TNFα, making this a poor candidate for functional analyses. Additionally, although NK 
cells can be incited to produce large amounts of GM-CSF (confirmed by ELISA), this 
cytokine was not detectable by flow cytometry, under various conditions. 
 
Gain of function is cell-intrinsic and not acquired during co-stimulation 
Though our data indicated that MHC I-deficient NK cells had gained functional capacity 
after residence in WT hosts, it remained possible that the observed gain of function was 
not the result of a cell intrinsic change in the MHC I-deficient NK cells, but rather simply 
due to a positive influence of WT splenocytes on the MHC I-deficient cells during the in 
vitro stimulation. To test the requirement for residency in WT hosts, as well as identify 
the gain of function of MHC I-deficient NK cells as cell-intrinsic or cell-extrinsic, we 
performed an in vitro experiment in which freshly isolated β2m-/- and WT splenocytes 
were mixed at various ratios and stimulated under the conditions utilized for the analyses 
of adoptively transferred cells. Regardless of the presence of WT cells in co-culture,  
β2m-/- NK cells retained their hyporesponsive phenotype following activating receptor 
crosslinking (Figure 7). Additionally, transfer of supernatant from stimulated WT 
splenocyte cultures to wells containing β2m-/- splenocytes did not result in increased 
functional capacity of β2m-/- NK cells. Therefore, during the in vitro co-culture, WT 
splenocytes did not impart gain of function to MHC I-deficient NK cells by either 
contact-dependent or contact-independent mechanisms. These results indicate that the 
gain of function of the β2m-/- NK cells following adoptive transfer to WT hosts is 
acquired during residence in the MHC class I-sufficient environment, not during co-
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culture and stimulation, and that the gain of function is likely due to a cell-intrinsic 
change in the β2m-/- NK cells. 
 
Gain of function is not consistent with a ‘memory’ phenotype 
It has been demonstrated that previously activated NK cells exhibit a memory-like 
property of enhanced cytokine production upon restimulation [65, 66]. Therefore, we 
sought to determine if our results could reflect prior donor NK cell activation. Prior 
studies showed that memory-like NK cells preferentially proliferate upon transfer [65, 
66]. By contrast, donor β2m-/- NK did not proliferate following residence in WT hosts, as 
evidenced by a lack of CFSE dilution (Figure 8a). Additionally, donor β2m-/- NK did not 
spontaneously produce IFNγ or display markers of activation, such as CD69, at any time 
from days 1-7 post-transfer (Figure 8b and data not shown). Taken together, these data 
indicate that β2m-/- NK cells were not activated following adoptive transfer to WT hosts, 
suggesting that acquisition of function is not due to the transition of β2m-/- NK cells to a 
‘memory-like’ state. 
 
Gain of function correlates with licensing 
We hypothesized that the gain in function of β2m-/- NK cells following their transfer to 
WT hosts was due to licensing of these cells. Ly49C is an inhibitory NK cell receptor 
with a strong ligand in the H-2b background, H2-Kb [67]. If transfer of hyporesponsive 
β2m-/- NK cells into an MHC I-sufficient environment results in licensing of β2m-/- NK 
cells, one should find a higher frequency of IFNγ+ cells among the Ly49C+ population 
than the Ly49C- population, as NK cells expressing a cognate inhibitory receptor for an 
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expressed MHC I molecule (in this case, Ly49C for Kb) would be capable of becoming 
licensed. Analyses were performed to examine the correlation between expression of 
Ly49C and production of IFNγ by donor NK cells, following adoptive transfer. When 
adoptively transferred β2m-/- NK cells were analyzed for Ly49C expression in parallel 
with IFNγ production, it was found that β2m-/- Ly49C+ NK cells do make IFNγ at a 
statistically significantly higher frequency than Ly49C- NK cells, following recovery 
from a WT host (Figure 9), suggesting that β2m-/- NK cells become licensed as a result of 
their residence in MHC I-expressing, WT hosts. 
 
Gain of function extends to cytotoxicity and degranulation 
MHC I-deficient NK cells demonstrate defects in cytokine production, as well as 
cytotoxicity, as compared to WT NK cells [28, 33]. To examine the gain of cytotoxic 
function in β2m-/- NK cells following adoptive transfer, we first performed a traditional 
51Cr release assay, using sorted donor β2m-/- NK cells as effectors, purified from WT 
hosts 7d post-AT. However, recovery of a low number of transferred cells permitted very 
few E:T conditions, giving these results limited value. 
 
Therefore, as an alternative to the direct cytotoxicity assay, we exposed transferred NK 
cells to sensitive targets and assessed the level of surface CD107a (LAMP-1), using 
antibody staining and flow cytometry. Surface expression of CD107a is used as a 
surrogate marker for NK cell cytotoxicity, as it is upregulated on the cell surface 
following degranulation, and killing is dependent upon degranulation [68]. Following 
transfer to MHC I-expressing hosts, β2m-/- NK cells gained the ability to degranulate at a 
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level equivalent to that of host and control WT NK cells in response to YAC targets 
(Figure 10). By contrast, β2m-/- NK cells adoptively transferred to β2m-/- hosts remained 
defective in degranulation, demonstrating levels comparable to Jinx NK cells, which 
cannot degranulate due to a mutation in Unc13d [55], and therefore serve as a negative 
control. Furthermore, as with cytokine production, we found no increase in the ability of 
freshly isolated β2m-/- NK cells to degranulate in response to target cells following co-
incubation with WT NK cells in vitro (Figure 11). Taken together, these data indicate that 
the gain in capacity for degranulation, and presumably cytotoxicity, observed in MHC I-
deficient cells is acquired following their residence in the WT host environment. 
 
To complement flow-based degranulation data regarding gain of cytotoxic function 
following adoptive transfer, the utility of a flow-based in vivo target rejection assay was 
assessed. In pilot experiments, WT NK cells were transferred to MHC I-sufficient, NK-
dysfunctional hosts (Jinx), to determine the maximum increase in cytotoxic capacity 
achievable following adoptive transfer of functional NK cells to an immunoreplete host. 
At day 7 post-AT, MHC I-deficient and MHC I-sufficient splenocyte targets were 
differentially labeled with CFSE and injected into these AT-recipient hosts. After 16-
24hr, mice were sacrificed and remaining targets were assessed by flow cytometry of host 
spleens. We noted only a very modest increase (about 4.5%) in the total in vivo killing 
capacity of Jinx mice which had previously received an adoptive transfer of WT NK cells 
7d before the target cell injection over untreated Jinx controls, even though the adoptively 
transferred WT NK cells were retained at a typical level (comprising ~10% of the host 
spleen at 7d post-AT). Therefore, the minimal change renders this in vivo target rejection 
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assay unrealistic for discriminating increase in cytotoxic capacity of MHC I-deficient 
cells following their transfer to lymphoreplete, MHC I-sufficient hosts (Figure 12). 
 
Gain of function is acquired 48-72 hours post-transfer 
Kinetic analyses were performed to more precisely determine the time required to 
establish the gain of function in MHC I-deficient NK cells, following their transfer to WT 
hosts. For these experiments, a large preparation of β2m-/- donor splenocytes was injected 
into many experimental (WT) and control (β2m-/-) recipients on day 0. Mice having 
received injections of cells from the common preparation were sacrificed on subsequent 
days following transfer, so that in each experimental time course, all hosts possessed cells 
from an identical starting pool, facilitating chronological comparison. The results of these 
analyses revealed that the gain of function in MHC I-deficient NK cells occurs 
approximately 3 – 4 days post-transfer to WT hosts, and remains stable through 7d 
(Figure 13). Additional analyses indicate that the gain of function holds until at least 14 
days post-AT. However, donor cell recovery is poor at these later time points, 
presumably due to continued elimination of MHC I-deficient grafts by WT host NK cells, 
hindering further analysis. 
 
Phenotype and tissue distribution of cells following adoptive transfer 
Previous studies indicate that splenic NK cells from β2m-deficient animals are mature 
and appear indistinguishable from peripheral NK cells in WT mice [46, 52, 69, 70]. 
Regardless, one potential mechanism for the gain of function by transferred β2m-/- NK 
cells could be differentiation of the cells following transfer. Phenotypic analyses at 7d 
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post-AT indicate that, regardless of the genotype of the host or donor, NK cells appeared 
indistinguishable in most aspects. For example, markers such as NK1.1, CD94, NKG2A, 
CD69, DX5, and 2B4 showed no difference in expression between β2m-/- and WT NK 
cells, before or after adoptive transfer (Figure 14). Interestingly, other markers, in 
particular activation receptors such as NKp46, NKG2D and CD11b, were expressed at a 
slightly higher level on WT NK cells when compared with β2m-/- NK cells, and their 
expression was slightly increased on β2m-/- NK cells following transfer to WT hosts.  The 
mechanism for the increase in activating receptor expression, as well as the significance 
of this increase, remains unknown. Overall, while there were small increases in the 
expression of some activating receptors, there were minimal changes in the expression of 
most surface molecules following adoptive transfer of β2m-/- cells to WT hosts. 
 
Tissue distribution of transferred and endogenous cells was compared following adoptive 
transfer of β2m-/- splenocytes to WT hosts. Peripheral organs (spleen, liver, thymus, LN 
and BM) were homogenized and examined via flow cytometry. There were no obvious 
differences, defects or abnormalities in the distribution of donor NK cells within the host, 
as compared to distribution of WT NK cells.  
 
Summary  
To more fully understand the processes surrounding NK cell education and licensing, as 
well as the potential for normal function in MHC I-deficient NK cells, we chose to utilize 
a system of adoptive transfer of MHC I-deficient NK cells to MHC I-sufficient, WT 
hosts. Surprisingly, we discovered that, although hyporesponsive in an MHC I-deficient 
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environment, MHC I-deficient NK cells can acquire normal functionality in MHC I+ 
hosts. Our results are the first to demonstrate that MHC I-deficient NK cells retain the 
capacity for normal function and that cell-intrinsic MHC I expression is not required for 
NK cell function.  
 
The gain of function observed for MHC I-deficient NK cells following their adoptive 
transfer to WT hosts applies to both NK-mediated cytokine production, as well as 
cytotoxicity, and does not appear to be related to either the maturation of these cells, nor 
the generation of a memory-like phenotype induced by activation. Additionally, this gain 
of function is cell-intrinsic, as it cannot be induced by co-stimulation with WT cells. 
Interestingly, we observed that NK cells expressing a cognate inhibitory receptor capable 
of interacting with the MHC I molecule are more likely to gain function than NK cells 
that do not express such a receptor. Therefore, consistent with all findings, we propose 
that this observed gain in function is due to licensing of the MHC I-deficient cells within 
the WT, MHC I-sufficient hosts, following exposure to MHC I molecules. 
 
The length of time required for the process of NK cell education or licensing has never 
before been experimentally determined. Our kinetic analyses reveal that the gain of 
function following adoptive transfer of MHC I-deficient NK cells to WT hosts requires 
approximately 72 hours. Given that our data suggest the gain of function is due to 
licensing of the MHC I-deficient NK cells, it is interesting to consider the implications of 
this time frame on the process of licensing. If the mechanism of licensing were governed 
by differential phosphosignaling events at the plasma membrane, or physical 
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rearrangement of existing signaling components, one may predict the induction of 
function to occur quickly, on the order of minutes. Instead, we observe that it takes days 
for MHC I-deficient NK cells to become functional following adoptive transfer. Perhaps 
these data indicate that licensing requires modifications within the cell, such as new 
transcription, new translation of transcripts and protein synthesis, and/or chromatin 
rearrangement. While experiments examining the transcriptome of licensed and 
unlicensed NK cells have been fairly uninformative (unpublished observation, personal 
communication, Joe Wahle), experiments examining the newly synthesized proteome 
(via ribosomal IP) or changes in chromatin accessibility (via ChIP) may be revealing. 
 
In conclusion, these data demonstrate that MHC I-deficient, hyporesponsive NK cells 
become functional following exposure to MHC I molecules expressed in WT hosts. 
Future experiments focus on the identification, as well as the necessary localization of 
molecules required to impart the gain of function, as well as for the maintenance of the 
functional phenotype and the potential for its reversal. 
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Figure 3. Transfer to an immunoreplete host does not activate WT NK cells. 
Splenocytes were purified from WT (C57BL/6) donors, CFSE-labeled and i.v. injected 
into unconditioned WT hosts. At 7d post-transfer, host spleens were harvested and NK 
cell phenotype was assessed via antibody staining for surface antigens, followed by flow 
cytometry. Cells are gated as NK1.1+CD3-CD19- and were examined for (a) surface 
phenotype, using CFSE+/- to discriminate donor and host cells, and (b) proliferation, as 
measured by CFSE dilution. Results are representative of 2 independent experiments. 
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Figure 4. Adoptive transfer to an immunodeficient host activates WT NK cells.  
Splenocytes were purified from WT (C57BL/6) donors, CFSE-labeled and i.v. injected 
into unconditioned Rag2-/-γC-/- and WT hosts. At 7d post-transfer, host spleens were 
harvested and NK cell phenotype was assessed via antibody staining for surface antigens, 
followed by flow cytometry. Cells are gated as NK1.1+CD3-CD19- and were examined 
for (a) surface phenotype, using CFSE+/- to discriminate donor and host cells, and (b) 
proliferation, as measured by CFSE dilution. Results are representative of 3 independent 
experiments. 
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Figure 5. MHC I-deficient NK cells gain ability to make IFNγ in response to 
stimulation, following transfer to WT hosts.  
β2m-/- splenocytes were purified, CSFE-labeled and i.v. injected into unconditioned WT 
and β2m-/- hosts. At 7d post-transfer, host spleens were harvested and total splenocytes 
stimulated via anti-NK1.1 antibody-mediated receptor crosslinking (PK136, 5µg/mL). 
Cells were stained for surface markers and intracellular IFNγ, then examined by flow 
cytometry. Plots depict IFNγ production versus Ly49C expression of donor (CSFE+) or 
host (CSFE-) NKp46+CD3- NK cells. Numbers indicate percentage of cells in each 
quadrant. Data are representative from 3 independent experiments. 
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Figure 6. Gain of function by MHC I-deficient NK cells following activation through 
an alternate stimulus.  
Summary of IFNγ production by Ly49C+ β2m-/- NK cells recovered 7d post-transfer to 
WT or β2m-/- hosts. On recovery, splenocytes were subjected to an 8hr ex vivo stimulation 
by activation receptor crosslinking via anti-Ly49H (3D10, 5µg/mL). Data are from 1 
experiment, with 2-4 mice/group. Means + standard error of the mean are shown. 
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Figure 7. MHC I-deficient and WT NK cells retain distinct cytokine production 
phenotypes during splenocyte co-culture.  
Freshly isolated splenocytes were purified from β2m-/-(Ly5.2) and Ly5.1 WT (C57BL/6) 
mice and plated at the indicated ratios. IFNγ production was assessed by flow cytometry 
after 8 hour ex vivo stimulation with plate-bound anti-NK1.1 (PK136, 5µg/mL), PMA + 
ionomycin (0.5µg/mL, 4µg/mL), or IL-12 + IL-18 (10ng/mL, 50ng/mL).  β2m-/- and WT 
cells were distinguished by anti-Ly5.2 antibody staining. Representative data from one of 
two experiments. 
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Figure 8. MHC I-deficient NK cells do not proliferate and do not constitutively 
produce IFNγ  following adoptive transfer into WT hosts.  
(a) Representative flow cytometry plot depicting CFSE intensity at day 7 post-transfer; 
cells were gated on forward and side scatter and NKp46+. (b) Summary of spontaneous 
IFNγ production by NK cells at day 7 post-transfer after 8 hours ex vivo culture in 
untreated media. Data are from 3 independent experiments, 3-5 mice/group. Means + 
standard error of the mean are shown. 
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Figure 9. MHC I-deficient Ly49C+ NK cells are more likely than MHC I-deficient 
Ly49C- NK cells to produce IFNγ after adoptive transfer to WT hosts. 
(a) IFNγ production by Ly49C+ (left) and Ly49C- (right) β2m–/– NK cells recovered from 
WT and β2m–/– hosts, 7d post-transfer, following anti-NK1.1 stimulation. (b) Direct 
comparison of IFNγ production by Ly49C+ and Ly49C- donor (β2m–/–) NK cells 
following anti-NK1.1 stimulation, 7d post-transfer to WT hosts. Data are pooled from 3 
independent experiments, with 3-5 mice/group.  Means are shown as horizontal lines with 
error bars representing standard error of the mean 
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Figure 10. MHC I-deficient NK cells gain WT degranulation capacity following 
adoptive transfer to MHC I-sufficient hosts.  
Splenocytes were purified from β2m-/- donors and adoptively transferred into WT, β2m-/- 
or Jinx hosts. On day 7 post-transfer, recipient splenocytes were harvested, co-incubated 
with YAC target cells and assayed for surface CD107a expression. (a) Representative 
contour plots showing CD107a expression on NK cells gated on Ly5.1+(donor) or Ly5.1- 
(host) CD3-NK1.1+ cells. Figures show % of cells positive for surface CD107a staining.  
(b) Summary of CD107a surface expression by host and donor NK cells following 
incubation with target cells. Data are representative from 3 independent experiments, 
with 2-3 mice/group for adoptive transfer donor and host cells, and 1-2 mice/group for 
controls. Means are shown as horizontal lines with error bars representing standard error 
of the mean. 
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Figure 11. MHC I-deficient and WT NK cells retain distinct degranulation 
phenotypes during splenocyte co-culture.  
Freshly isolated splenocytes were purified from β2m-/-(Ly5.2) and Ly5.1 WT (C57BL/6) 
hosts and plated at the indicated ratios. NK cells were assessed via flow cytometry for 
surface CD107a expression after 2 hour stimulation with YAC or RMA target cells (E:T, 
1:1), or PMA + ionomycin (positive control), or PBS (negative control). β2m-/-and WT 
cells were distinguished with an anti-Ly5.2 antibody. Representative data from one of 
two experiments. 
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Figure 12. Adoptive transfer of competent NK cells has only a small impact on 
cytotoxicity in NK-dysfunctional, immunoreplete hosts.  
WT splenocytes were adoptively transferred to Jinx hosts, and at 7d post-transfer, 
differentially labeled WT and β2m-/- splenocytes (target cells) were i.v. injected in the 
previous adoptive transfer recipients, as well as into WT and Jinx controls. Recipient 
mice were sacrificed 16 – 24hr post-target injection, and spleens were assessed for 
remaining target cells, using flow cytometry. The ratio of β2m-/-:WT targets remaining is 
shown. 
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Figure 13. MHC I-deficient NK cells gain function approximately 72 hours following 
transfer into WT hosts.  
Summary of IFNγ production by NK cells recovered 1 – 7 days after adoptive transfer 
into WT hosts, following anti-NK1.1 stimulation. Data are pooled from 7 independent 
experiments, with 1 -3 mice/group (β2m-/- → β2m-/-) and 2-8 mice/group (β2m-/- → WT). 
Means + standard error of the mean are shown. 
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Figure 14. Minimal changes in surface phenotype of MHC I-deficient NK cells 
following adoptive transfer to WT hosts.  
At day 7 following adoptive transfer of β2m-/- splenocytes to WT hosts, unstimulated NK 
cells were assessed for NK receptor or marker expression by flow cytometry. Control 
staining of NK cells from unmanipulated WT or β2m-/- mice is shown. Data are 
representative from 2 experiments per condition, with each point representing one 
individual spleen. Average MFI (mean fluorescence intensity) are shown as horizontal 
bars. *p < 0.02, **p < 0.002, ***p < 0.0005. 
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CHAPTER 4: 
Identification and necessary localization of receptors and ligands  
required for NK cell licensing 
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Our initial results indicated that hyporesponsive, MHC I-deficient NK cells could become 
functional following exposure to MHC I molecules in WT hosts, in a mechanism that 
appeared to be licensing. We wished to confirm and extend these findings by 
investigating the effect of interaction between different pairs of inhibitory receptors and 
their cognate MHC I ligands on the licensing status of MHC I-deficient NK cells. 
Additionally, restriction of the location and identity of host-MHC I expression allows for 
the determination of tissues and cell types responsible for conferring function, as well as 
provides insight into the correct placement and physical orientation of receptors and 
ligands necessary to successfully impart the licensed phenotype.  
 
Introduction 
The education of NK cells has been observed for many different pairings of inhibitory 
receptors and their ligands [41, 71, 72], lending credit to the hypothesis that licensing is a 
universal mechanism by which NK cells gain functional competence. While specific 
identities of receptors and ligands comprising a complete functional pair have been 
documented, important questions remain regarding the physical orientation and 
localization of functional contact between these molecules. An important question 
concerns the identity of the cell which must express the educating MHC I ligand. While 
seemingly straightforward, this problem is complicated by the fact that NK cells 
themselves express both inhibitory receptors and their ligands, MHC I molecules. 
Therefore, there is potential that an NK cell may be licensed by contact between these 
molecules on the surface of the same cell (binding in cis), or by contact between the 
receptor and an MHC I molecule expressed on a different cell (binding in trans) [73-77]. 
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In a related idea, if it is demonstrated that NK-intrinsic expression of MHC I is not 
sufficient to establish normal function, then one must question which cell types are 
required to express MHC I for the generation of licensed NK cells. These results have 
particular relevance within the field of human bone marrow transplantation, as tissue 
restriction of MHC I (HLA) in licensing could have important functional consequences 
when hematopoietic and non-hematopoietic compartments are of different origin 
(genetically non-identical). 
 
Before this thesis work, MHC I-deficient NK cells had never been demonstrated to have 
the capacity to become functional. This precluded an isolated study of the individual 
contributions of trans or cis binding to licensing, and prevented precise identification of 
cell types which must express MHC I molecules for licensing, as the contribution of NK-
intrinsic MHC I expression remained a complicating factor. Armed with evidence that 
MHC I-deficient NK cells can gain functional capacity in a mechanism believed to be 
licensing, we sought to firmly establish the gain of function as licensing, by extending the 
observed phenomenon to multiple pairings of inhibitory receptors and MHC I ligands. 
Subsequently, we utilized the transfer of MHC I-deficient NK cells to hosts with 
differential localization of MHC I expression, in order to definitively determine the 
relative contributions of trans and cis binding to NK cell licensing, as well as the tissue(s) 
responsible for conformation of the licensing phenotype. 
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Gain of function holds for multiple inhibitory receptor:MHC I ligand pairs 
Our initial results indicated that following adoptive transfer of MHC I-deficient 
splenocytes into MHC I-expressing hosts, there was in increase in the ability of 
previously hyporesponsive MHC I-deficient NK cells to make IFNγ after stimulation 
through their activating receptors. Additionally, it appeared that acquisition of function 
was due to licensing of the transferred NK cells, as cells expressing an inhibitory receptor 
capable of interacting with host MHC I displayed a preferential gain of function. 
 
To confirm that the observed gain of function was due to licensing, we expanded our 
search to alternate pairings of inhibitory receptors and their MHC I ligands, testing the 
ability of these interactions to induce function in MHC I-deficient NK cells. In the these 
experiments, we transferred β2m-/- NK cells into KODO D8 hosts (Kb-/-Db-/-Dd+), which 
lack H2b MHC class Ia heavy chains and display transgenic expression of H2Dd, a ligand 
for Ly49A [31]. KODO D8 host spleens were recovered 7d post-AT and splenocytes 
were stimulated via crosslinking of the NK1.1 receptor. On analysis, we noted a gain in 
production of IFNγ by Ly49A+ MHC I-deficient NK cells (Figure 15), consistent with 
licensing of Ly49A+ NK cells in H2Dd-expressing mice [41].  Thus, we confirmed that 
following adoptive transfer to an MHC I-expressing environment, there was a selective 
gain of function for transferred MHC I-deficient NK cells expressing another inhibitory 
receptor able to bind to a different host MHC I molecule. These results further supported 
our hypothesis that exposure to host MHC I results in licensing of MHC I-deficient NK 
cells. 
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Specific interaction between an inhibitory receptor and its cognate MHC I ligand is 
required for gain of function 
Our results indicated that the subset of NK cells expressing an inhibitory Ly49 receptor 
capable of interacting with an expressed host MHC I molecule possess a greater capacity 
for cytokine production than NK cells lacking such a receptor. Interestingly, we also 
consistently observed that, although not statistically significant, inhibitory receptor-
negative NK subsets (that is, Ly49C– NK cells in WT hosts and Ly49A– NK cells in 
KODO D8 hosts) trended towards greater IFNγ production than their counterpart subsets 
(identified as receptor-negative) from MHC class I-deficient mice (Figure 9a).  It then 
became important to consider that exhaustive staining of all inhibitory receptors was not 
performed in these assays, and it remained possible that cells negative for the inhibitory 
receptor of interest expressed another, undetected, inhibitory receptor. Therefore, we 
hypothesized that, as inhibitory Ly49 receptors exhibit both redundancy as well as 
promiscuity in MHC I-binding [78-85], perhaps expression of other self-MHC-specific 
receptors may be responsible for the observed increase in function of ‘receptor-negative’ 
NK subsets in MHC I-expressing environments. 
 
To investigate this hypothesis, we wished to restrict the expression of inhibitory Ly49 
receptors and MHC I alleles in such a way that only one functional pairing was present. 
At present, there is no mouse with targeted deletion of the NKC (NK gene complex, the 
genetic locus of Ly49 alleles and other NK receptors) or components of the NKC, 
making it impossible to restrict inhibitory receptor expression. Therefore, in order to limit 
the number of functional pairings, we turned to restriction of the MHC I alleles 
 - 70 - 
expressed. To accomplish this, we utilized the TKO SCT-Kb Tg mouse (triple knock-out, 
single chain trimer Kb-OVA transgenic), generated and generously provided by the 
laboratory of Dr. Ted Hansen (Washington University) [54, 86]. Through targeted 
deletion, these mice lack the genes necessary for endogenous MHC Ia expression (TKO = 
Kb-/-Db-/-β2m-/-). Instead, these mice transgenically express, as a single peptide, the MHC I 
heavy chain H2Kb covalently bound to β2-microglobulin and the SIINFEKL peptide from 
ovalbumin, which occupies the peptide-binding cleft. It has been previously demonstrated 
that, among inhibitory receptors expressed in the C57BL/6 NKC, Ly49C is the sole 
inhibitory Ly49 receptor capable of binding to the SCT-Kb molecule [41] . Use of these 
mice as recipients in our adoptive transfer system thus allowed us to effectively restrict 
the inhibitory receptor:MHC I pairings to a single pair, Ly49C and SCT-Kb. 
 
Following our standard protocol, β2m-/- splenocytes were adoptively transferred to the 
SCT recipients. On recovery and stimulation at 7d post-AT, we observed that donor 
Ly49C+ NK cells gained the ability to produce IFNγ at levels equivalent to that of host 
Ly49C+ cells (Figure 16), as predicted. However, in contrast to the results from transfer 
to WT hosts, where it was suspected that multiple receptor:ligand pairs license, we now 
observed no increase in IFNγ production by either donor or host inhibitory receptor-
negative (i.e. Ly49C–) NK cells. These results allowed us to conclude that the interaction 
between an inhibitory Ly49 receptor and its cognate self-MHC I ligand is absolutely 
required for the gain of function observed in hyporesponsive MHC I-deficient NK cells 
following their adoptive transfer to MHC I-sufficient hosts, consistent with licensing of 
these cells. 
 - 71 - 
MHC Ib molecules do not induce gain of function in MHC I-deficient NK cells 
Thus far, we have limited our consideration of inhibitory receptor ligands to the classical 
MHC I alleles (i.e. MHC Ia). However, there is evidence that contact with non-classical, 
MHC Ib molecules, such as murine Qa-1 and human HLA-E, may endow NK cells with 
capacity for enhanced responsiveness, through interaction with the inhibitory 
NKG2A/CD94 receptor [49-51]. It is unclear if the apparent increased functional capacity 
following recognition of these MHC Ib ligands operates via the mechanism of licensing.  
 
To investigate the role of MHC class Ib β2m-associated molecules in gain of function of 
MHC I-deficient NK cells, β2m-/- NK cells were transferred to KODO (Kb-/-Db-/-) hosts, 
which lack expression of MHC Ia alleles, but do express β2m-associated, MHC Ib 
molecules. Seven days post-AT, spleens were removed and NK cells were stimulated via 
crosslinking of NK1.1. In contrast to results obtained following transfer to WT hosts, 
here we found no significant increase in cytokine production by β2m-/- NK cells upon 
recovery from hosts expressing only MHC Ib molecules (Figure 17a). Therefore, we can 
conclude that in the absence of MHC I heavy chains, MHC class Ib molecules likely do 
not contribute to licensing. Interestingly, in my hands, I also found no statistically 
significant difference in the ability of WT NKG2A+ and NKG2A- NK cells to produce 
IFNγ in response to anti-NK1.1 stimulation, further arguing against a licensing function 
for NKG2A, via contact with non-classical MHC I molecules, such as Qa-1 (Figure 17b).  
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Inverse correlation between gain of function and inhibitory receptor MFI 
Although the phenotype of β2m-/- and WT NK cells remained remarkably similar both 
before and following adoptive transfer (as described in Chapter 3), we did notice a 
distinct and reproducible decrease of Ly49C mean fluorescence index (MFI) on MHC I-
deficient cells following adoptive transfer to WT hosts (Figure 18a). This effect was 
observed for multiple inhibitory Ly49 receptors in the presence of a known MHC I ligand 
(Figure 18a-c). The decrease in MFI was determined to be specific, as the MFI of Ly49C 
was decreased in β2m-/- cells transferred to the TKO SCT-Kb Tg mice (Fig 18b), but the 
MFI of Ly49A, a receptor for which no MHC I ligand is present in this host, remained 
unchanged (Fig 18d). Decreased Ly49 MFI appears to reflect a specific interaction of an 
inhibitory receptor on a donor NK cell with a host MHC I molecule. The decrease in MFI 
could be due to an actual reduction in the amount of inhibitory receptor present at the 
surface of the NK cell, possibly via endocytosis of the inhibitory receptor following 
reception of signal. This has been observed for other NK cell receptors, such as NKG2A, 
which has been reported to recycle between the cell surface and early endosomes [87, 
88]. 
 
Cis ‘masking’ hypothesis  
An alternative, though not mutually exclusive, explanation for the decreased inhibitory 
receptor MFI observed on MHC I-deficient NK cells following their adoptive transfer to 
MHC I-sufficient hosts is that of the ‘masking’ hypothesis. This hypothesis states that 
interactions between inhibitory receptors and their MHC I ligands can block access to the 
antibody-binding epitope on the inhibitory receptor, leading to a falsely low MFI when 
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receptor expression is quantified via flow cytometry [75, 89]. It is important to note that 
NK cell receptor-ligand interactions can occur in trans (on different cells) or in cis (on 
the same NK cell). Thus, while the normal orientation of most receptor:ligand 
interactions is assumed to be in the trans orientation, these ‘masking’ interactions are 
believed to occur in the cis orientation.  
 
In support of the masking theory, crystal structures of the inhibitory Ly49 proteins reveal 
great flexibility in their membrane-proximal ‘stalk’ domains, making it theoretically 
possible for inhibitory receptors to bind MHC I in the cis orientation [90, 91]. It has been 
noted that in mice expressing an MHC I ligand for an inhibitory Ly49 receptor, the 
inhibitory receptor MFI is lower than in mice which do not express a ligand [76, 92-96], 
possibly due to the masking of inhibitory receptor epitopes in cis. Experimental evidence 
further supporting the masking hypothesis comes from studies in which, after a brief 
exposure to acid treatment, the inhibitory receptor MFI is shown to increase on NK cells 
from mice expressing the cognate MHC I ligand [75], presumably due to disruption of cis 
interactions.  
 
As discussed, there is experimental evidence for cis binding between NK cell receptors 
and their MHC I ligands. However, the masking explanation is difficult to reconcile with 
the results of decreased inhibitory receptor MFI observed in our adoptive transfer system, 
as MHC I-deficient NK cells do not express surface MHC I and should therefore be 
incapable of establishing cis binding interactions between inhibitory receptors and MHC 
I molecules. Thus, the masking hypothesis alone is insufficient to account for the 
 - 74 - 
decreased inhibitory receptor MFI observed on MHC I-deficient NK cells following their 
adoptive transfer to MHC I expressing hosts.  
 
‘Trogocytosis’ of MHC I  
While the masking hypothesis alone is insufficient to explain our previous result of 
inhibitory receptor downregulation, as donor cells do not have endogenous expression of 
MHC I, the hypothesis could become valid if an MHC I-deficient donor NK cell 
somehow acquired MHC I on its surface. Although this idea may seem implausible, 
numerous reports indicate that lymphocytes, including NK cells, can acquire plasma 
membrane components from other cells, in a process termed trogocytosis [93, 97-100]. 
We hypothesized then, that if through the mechanism of trogocytosis donor (β2m-/-) NK 
cells acquired surface MHC I ‘expression’, it might be possible that the decrease in 
inhibitory receptor MFI on MHC I-deficient NK cells following their transfer to MHC I-
sufficient hosts was due, at least in part, to cis-masking of the inhibitory receptor 
epitopes. We predicted that the transfer of MHC I molecules could be accomplished by 
several, non-mutually exclusive mechanisms, including: 1) surface stabilization of donor 
(β2m-/-) MHC I heavy chains (Kb, Db) by free β2m present in host serum, 2) direct transfer 
of the β2m molecule from the surface of a host (MHC I+) cell and stabilization of 
endogenous donor heavy chain, and/or 3) transfer of the entire, intact (host-derived) 
MHC I molecule to the surface of donor cells. 
 
To explore the potential for transfer of MHC I molecules to the surface of MHC I-
deficient NK cells, we examined the surface of β2m-/- splenocytes for the presence of 
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MHC I molecules following their adoptive transfer to WT hosts. At 7d post-AT, 
splenocytes were recovered, stained with antibodies to the MHC Ia molecule H2Kb, and 
analyzed via flow cytometry. It was immediately apparent that following exposure to 
MHC I-expressing cells, MHC I-deficient splenocytes had acquired a small amount of 
surface MHC I (Figure 19a). This amount was calculated to be approximately 5% of the 
amount of MHC I present on the surface of WT cells (MFI = 913 vs. 26424). 
Interestingly, NK cells, which posses MHC I-specific receptors such as the Ly49s, 
displayed a greater amount of transferred MHC I than other lymphocytes (such as T 
cells), supporting the idea that MHC I transfer may occur via a receptor-specific transfer 
mechanism (Figure 19a). 
 
While these data supported the idea that MHC I could be transferred to the surface of 
MHC I-deficient cells, the results did not allow us to discriminate which mechanism, 
transfer of β2m molecules and/or transfer of intact MHC I, was responsible for the 
increase in surface expression. To further explore this question, we performed adoptive 
transfer of β2m-/- splenocytes to TKO SCT-KbOVA recipients, which lack expression of 
β2m, Kb and Db, but do express one MHC I molecule, Kb-OVA, as a covalently linked 
single peptide. Because these mice do not express free β2m, they cannot stabilize 
endogenous MHC Ia heavy chain expression and any transfer of MHC I to β2m-/- 
splenocytes must occur only through the transfer of intact, MHC I molecule. Upon 
recovery and analysis at 7d post-AT, we stained for the presence of surface Kb-OVA, 
using a monoclonal antibody that does not cross-react with either native Kb or Db [101]. 
Our results clearly indicate that β2m-/- splenocytes do display a small amount of Kb-OVA 
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on the cell surface, following their recovery from SCT hosts (Figure 19b), indicating that 
transfer of the entire, intact MHC I molecule had occurred. While these results do not 
absolutely preclude a role for the transfer of free β2m to the surface of β2m-/- cells after 
transfer to WT hosts, they do demonstrate that transfer of intact MHC I to the surface of 
MHC I-deficient splenocytes can occur. 
 
Although our findings indicated that MHC I could be transferred to the surface of β2m-/- 
splenocytes, we questioned whether this transfer may be an irregularity, owing to the 
high level of inhibitory receptor expression on the surface of MHC I-deficient cells 
(Figure 18). Therefore, to investigate the potential for transfer of MHC I molecules to 
cells expressing a full complement of endogenous MHC I, WT splenocytes were 
adoptively transferred to SCT mice. Following recovery at 7d post-AT, cells were stained 
with an antibody specific for Kb-OVA, as well an antibody against endogenous Kb, and 
analyzed by flow cytometry. The results indicated that WT cells had acquired a small but 
significant amount of surface Kb-OVA (Figure 19c), leading us to conclude that MHC I 
transfer is not restricted to only those cells lacking endogenous, surface MHC I 
expression.  
 
Having firmly established the possibility of MHC I transfer, we wished to determine if 
this and ensuing cis interactions between inhibitory receptors and transferred MHC I 
molecules may account for the decrease in inhibitory receptor MFI observed following 
adoptive transfer of MHC I-deficient cells to MHC I+ hosts. To investigate, we 
established co-cultures of β2m-/- splenocytes with WT and SCT splenocytes. In these 
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experiments, we included staining for simultaneous expression of surface MHC I and 
MHC I-specific inhibitory receptors. We found that although the highest observable level 
of MHC I transfer was achieved during co-culture (~5%), β2m-/- inhibitory receptor MFI 
was only slightly diminished (Figure 20). In other words, the maximum level of MHC I 
transfer can occur in the absence of full inhibitory receptor downregulation. So, while 
MHC I transfer and resultant cis masking do appear to have a small impact on inhibitory 
receptor MFI, MHC I transfer alone cannot account for the decreased MFI observed on 
MHC I-deficient splenocytes, following their exposure to MHC I molecules. 
 
While the concept of ‘masking’ likely does not explain the decreased inhibitory receptor 
MFI, it does raise some important questions regarding the interaction of the inhibitory 
receptors and their MHC I ligands within our adoptive transfer system, leading to an 
interesting consideration of the functional implications of the physical orientation of 
these molecules during their contact. 
 
Trogocytosis of MHC I occurs in adoptive transfer, but does not correlate with 
increased functional capacity 
Although we initially anticipated only the existence of trans interactions between donor 
inhibitory receptors and host MHC I within our adoptive transfer system, cis interactions 
had been demonstrated feasible, through the mechanism of MHC I transfer. Thus, while 
the results primarily indicated that MHC I-deficient cells became licensed by interactions 
with host MHC I in trans, the importance of interactions in cis could not be discounted. 
By concurrently examining the gain in function of MHC I-deficient NK cells and their 
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acquisition of host MHC I, we could determine if there was a correlation between surface 
MHC I expression and function, thereby directly assessing the significance of cis 
interactions in the process of NK cell licensing. 
 
In order to address the importance of cis interactions in licensing, we performed an 
adoptive transfer of β2m-/- splenocytes to SCT hosts, as previously described. Splenocytes 
were harvested, stimulated, and prepared for flow cytometry analysis by staining for 
intracellular IFNγ, as well as surface MHC I and other markers. The results from these 
analyses demonstrated that there was no correlation between expression of surface MHC 
I (i.e. MHC I transfer), and functional capacity, in the form of cytokine production 
(Figure 21). MHC I-deficient donor NK cells that had acquired host MHC I molecules 
were no more or less likely to produce IFNγ than donor cells that had not acquired 
surface MHC I, or host NK cells with normal MHC I expression. Thus, adoptive transfer 
studies indicate that cis interactions do not appear to establish function in MHC I-
deficient NK cells, and that trans interactions are likely sufficient to fully license NK 
cells, as exposure of MHC I-deficient cells to an MHC I-sufficient environment imparts 
normal function. 
 
MHC I expression is required on both hematopoietic and non-hematopoietic cells for 
gain of function following adoptive transfer 
Results from adoptive transfer studies using MHC I-deficient NK cells indicated cell-
intrinsic MHC I expression was not required for licensing. While it was determined that 
some component of the environment must display MHC I for licensing to occur, the 
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adoptive transfer studies did not reveal the identity of the cell type in which MHC I 
expression was required. We hypothesized that for proper establishment of NK cell 
licensing, MHC I expression may be required on a hematopoietic cell, a non-
hematopoietic cell, or both. 
 
In order to test these hypotheses, we revisited the historical system of bone marrow 
chimeras. Although data from bone marrow chimeras had previously been unable to 
provide clear answers regarding the contribution of MHC I expression to NK cell 
function, we believed that armed with methods of single-cell analysis, chimeras could be 
an informative experimental system. Using this model, we proceeded to investigate 
which compartment(s) must express MHC I for NK cells to become licensed. 
 
In order to determine if MHC I expression is necessary on hematopoietic, non-
hematopoietic or both types of tissue to confer NK licensing, bone marrow chimeras with 
MHC I-expression in either hematopoietic or stromal compartments (β2m-/-  WT and 
WT  β2m-/-) were generated. Analyses of the chimeras indicate that expression of MHC 
class I on either compartment alone is insufficient to generate functional NK cells, 
necessitating MHC I expression on both hematopoietic as well as non-hematopoietic cells 
for proper NK cell function (Figure 22). Additionally, results from mixed chimeras, in 
which WT BM is titrated at increasing ratios with β2m-/- BM and engrafted in WT hosts, 
indicate that NK cells appear sensitive to the total amount of MHC I in the environment. 
Both WT as well as β2m-/- NK cells display greater function as the amount of MHC I is 
increased. Importantly, these results refute the theory of ‘dominant tolerance’ [56], which 
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predicts only a decrease in WT function, but does not predict or account for the 
concurrent gain of function observed in MHC I-deficient cells upon mixing with WT 
cells, as is experimentally observed. 
 
Summary 
The results described in this chapter demonstrate that the gain of function following 
adoptive transfer appears to be a general mechanism, like licensing, as it holds for a 
variety of inhibitory receptor:MHC Ia ligand pairs. Also, following transfer of MHC I-
deficient NK cells to MHC I+ hosts, we showed that specific contact between an 
inhibitory receptor and cognate MHC I ligand is absolutely required for gain of function, 
consistent with licensing of these cells. In a setting where the pairings of inhibitory 
receptor and MHC I were restricted to a single pair (Ly49C and SCT-Kb), only those NK 
cells with expression of Ly49C showed normal functional capacity following stimulation.  
 
Interestingly, we did not find the general mechanism of licensing to be applicable to the 
interaction of inhibitory receptors with non-classical, MHC Ib ligands. However, there is 
one notable caveat within these particular experiments: Qa-1, the MHC Ib molecule 
predicted to act as the MHC Ib licensing ligand, is fairly dependent upon the presence of 
Kb/Db leader peptide fragments for its expression [20, 102]. It is possible then that KODO 
mice may have abnormally low expression of Qa-1, as they are lacking the genes for Kb 
and Db (and therefore expression of the leader peptides). In our experiments, normal Qa-1 
surface expression was not verified by flow cytometry. Therefore, a more stringent and 
accurate test of the role of Qa-1 in NK cell licensing could be obtained using, as hosts, 
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KODO mice with Tg expression of Kb and/or Db leader peptides, or β2m-/- hosts with Tg 
expression of a Qa1-β2m-peptide single chain trimer molecule. Regardless, data 
comparing the function of NK cells from a WT environment (i.e. Qa-1+) indicated that 
NK cells with expression of NKG2A, the inhibitory receptor for Qa-1, did not appear to 
possess greater functional capacity than NK cells lacking this receptor, arguing against a 
role for this interaction in licensing.  
 
Results from adoptive transfer and co-culture provide new insight into the requirement 
for specific physical orientation of the contact between NK cell inhibitory receptors and 
MHC I molecules to induce licensing. Following exposure to MHC I+ environments, 
transfer of MHC I molecules to the surface of MHC I-deficient donor cells is detectable, 
though this alone does not account for the observed downregulation in inhibitory receptor 
expression. While MHC I transfer could allow for cis interactions between inhibitory 
receptors and MHC I on the surface of donor NK cells, it appears that interactions in 
trans are sufficient to license, as we observed no correlation between ‘surface’ MHC I 
expression on donor (β2m-/-) NK cells and their ability to produce IFNγ after recovery 
from MHC I+ hosts. 
 
As it cannot be fully explained by MHC I transfer and subsequent interactions in cis, the 
mechanism of inhibitory receptor downregulation following adoptive transfer of MHC I-
deficient cells to MHC I+ hosts remains an interesting subject for investigation. In 
accordance with the behavior of many other signaling receptors [103-105], it is likely that 
the decrease in inhibitory receptor MFI reflects a real decrease in the amount of protein 
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present at the cell surface, due to receptor internalization following ligand engagement. 
Using techniques such as immunoprecipitation, western blot, and surface labeling 
(biotinylation), it may be possible to quantify the actual amount of inhibitory receptor 
present at the cell surface. Additionally, confocal microscopy of NK cells utilizing co-
staining of markers of intracellular trafficking, such as the Rab proteins, may be useful to 
determine in which vesicles inhibitory Ly49 receptors are located. Results could provide 
information regarding the trafficking and/or recycling patterns of these receptors, 
possibly revealing aspects of the regulation of their surface expression. The fluctuation in 
NK cell inhibitory receptor expression is conceptually interesting, particularly when one 
considers that these receptors, unlike many other signaling receptors, may have constant 
access to their ligand. In this case, maintenance of a functional receptor repertoire at the 
NK cell surface is far more than trivial. Investigations into the mechanisms responsible 
for the downregulation of NK inhibitory receptor expression following exposure to MHC 
I would certainly be of value. 
 
Finally, our results indicate that neither stromal nor hematopoietic expression alone of 
MHC I is sufficient for generation of licensed NK cells. Bone marrow chimeras reveal a 
‘bidirectional’ effect of mixing WT and MHC I-deficient NK cells, resulting in an 
intermediate phenotype. These results refute the theory of ‘dominant tolerance’, which 
would predict only a decrease in WT NK function but not an increase in function of  β2m-
/- NK cells, which is observed. Also, we observed that even a small decrease in the 
amount of MHC I present in the host appeared to have a large negative impact on the 
function of the entire NK cell population. 
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These results may allow for the generation of hypotheses regarding the temporal aspects 
of MHC I contact required for licensing. For example, if licensing is a permanent event 
established by a single contact (or contact event) with an MHC I molecule, a small 
decrease in MHC I expression may have very little effect on the licensed status of the 
entire population. One could predict that the time required to license an entire population 
might increase if access to ‘resources’ (i.e. MHC I) is decreased, but given long enough, 
the population will complete the transition. An analogous situation would be that of a 
chemical reaction, with the formula A + B  C. Here, ‘A’ represents an NK cell with an 
inhibitory receptor specific for MHC I, ‘B’ represents MHC I and ‘C’ represents a 
licensed NK cell. If one contact with MHC I is sufficient to license, this becomes an 
irreversible reaction and we will never see C  A (+B), or cells becoming unlicensed. 
Over time (provided there are sufficient molecules of ‘B’ or ‘B’ is not consumed), all ‘A’ 
will be consumed. In other words, if there is MHC I in the environment, all NK cells will 
become licensed.  
 
However, if continuous or repeated contact with MHC I is required to maintain the 
licensed phenotype, even a small decrease in available MHC I would negatively affect 
the entire population. This is best conceptualized as a function of mathematical 
probability over time. At each instant, there is some probability that an NK cell will 
encounter MHC I and become licensed. If environmental MHC I is decreased, the 
probability for that particular time point is also decreased. If we examine the population 
of NK cells over a longer period of time and we assume they must make repeated 
contacts with MHC I to become/stay licensed, the probability they will be licensed at the 
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end of this time is the product of all probabilities over time. Therefore, even a small 
decrease in the probability at one instant has a massive impact on the final outcome, as it 
is multiplied over time.  
 
In the next chapter, the requirement for continuous contact with MHC I molecules is 
explored when we examine the components necessary to maintain the licensed 
phenotype, as well as the potential for its reversal. 
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Figure 15. Gain of function holds for another inhibitory receptor:self-MHC I pair. 
Summary of IFNγ production by Ly49A+ (left panel) and Ly49A- (right) donor (β2m–/–) 
and host NK cells recovered 7d post-adoptive transfer from KODO D8 (KD8) or β2m–/- 
hosts, following ex vivo anti-NK1.1 stimulation. Results from anti-NK1.1 stimulation of 
unmanipulated KODO D8 NK cells are shown. Data were pooled from 4 independent 
experiments, with 3-8 mice/group. Means are shown as horizontal lines with error bars 
representing standard error of the mean. 
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Figure 16. Inhibitory receptor and cognate MHC I ligand are required for gain of 
function.   
Summary of IFNγ production by Ly49C+ (left panel) or Ly49C- (right) donor (β2m–/–) and 
host NK cells recovered 7d post-adoptive transfer from TKO SCT-Kb Tg (SCT) or β2m–/– 
hosts, following ex vivo stimulation via anti-NK1.1. Results from anti-NK1.1 stimulation 
of unmanipulated SCT NK cells are shown.  Data were pooled from 3 independent 
experiments with 3-7 mice/group.  Means are shown as horizontal lines with error bars 
representing standard error of the mean. 
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Figure 17. MHC Ib ligands do not appear to license NK cells. 
(a) Summary of IFNγ production by NKG2A+ (left panel) or NKG2A- (right) donor 
(β2m–/–) or host NK cells recovered 7d post-adoptive transfer from KODO hosts, 
following ex vivo stimulation via anti-NK1.1. Results from anti-NK1.1 stimulation of 
unmanipulated KODO and WT NK cells are shown.  Data were pooled from 2 
independent experiments with 2-4 mice/group.  Means are shown as horizontal lines with 
error bars representing standard error of the mean. (b) Summary of IFNγ production by 
NKG2A+ (left panel) or NKG2A- WT NK cells, following ex vivo stimulation via anti-
NK1.1. Data are pooled from 2 experiments, with 3 mice/group. 
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Figure 18. Specific reduction in inhibitory Ly49 receptor expression on MHC I-
deficient donor NK cells following adoptive transfer into MHC I-expressing hosts. 
Splenocytes from β2m-/- donors were adoptively transferred into indicated hosts. At day 7, 
unstimulated recipient splenocytes were assessed for (a, b) Ly49C or (c, d) Ly49A 
surface expression. Control staining from unmanipulated mice are shown, as indicated.  
Data are from 2-3 experiments per condition, with each point representing one individual 
spleen. Average MFI (mean fluorescence intensity) are shown as horizontal bars. **p < 
0.004, ***p < 0.0001. 
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Figure 19. NK cells acquire surface MHC I from surrounding cells. 
β2m-/- or WT splenocytes were CFSE-labeled and adoptively transferred to indicated 
hosts. Surface MHC I expression was assessed via flow cytometry 7d post-transfer. (a) 
Surface expression of H2Kb on β2m-/- donor and WT host splenocytes. (b) Surface 
expression of Kb-OVA on β2m-/- donor and TKO SCT Kb-OVA host splenocytes. (c) 
Surface expression of Kb-OVA on WT donor and TKO SCT Kb-OVA host splenocytes. 
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Figure 20. Acquisition of surface MHC I does not correlate with inhibitory Ly49 
receptor downregulation on MHC I-deficient NK cells. 
Freshly isolated (a) β2m–/– and WT Ly5.1 splenocytes or (b) β2m–/– and TKO SCT Kb-
OVA splenocytes were co-incubated in normal medium for the times indicated. After 
incubation, cells were stained for surface expression of MHC I and Ly49C, and analyzed 
via flow cytometry. 
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Figure 21. Acquisition of surface MHC I does not correlate with gain of function in 
MHC I-deficient NK cells. 
Splenocytes from β2m-/- donors were adoptively transferred into WT hosts. Upon harvest, 
host and donor NK cell populations (gated as CD3-NKp46+CFSE+/-) were stained for 
surface H2Kb expression and intracellular IFNγ, following anti-NK1.1 stimulation. 
Histograms of surface Kb expression for host and donor NK cell populations determined 
to be positive or negative for intracellular IFNγ are shown. 
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Figure 22. MHC I expression is required on both hematopoietic and non-
hematopoietic cells for NK cell function. 
Eight to ten weeks after their generation, NK cell function was assessed in bone marrow 
chimeras with varying hematopoietic and non-hematopoietic MHC I expression (as 
indicated). Splenocytes were stimulated via anti-NK1.1 treatment and stained for 
intracellular expression of IFNγ. WT and β2m-/- cells were individually identified by 
allelic variation at the CD45 locus (Ly5.1 vs. Ly5.2). 
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CHAPTER 5: 
Factors contributing to maintenance of the licensed phenotype  
and potential for its reversal 
 - 102 - 
Initial experiments of this thesis project focused on determining the potential for normal 
function by MHC I-deficient NK cells, as well as identity and localization of the 
environmental components necessary for induction of normal function, following transfer 
to MHC I-sufficient hosts. With these parameters established, we turned our investigation 
to factors that contribute to the preservation of the licensed phenotype in WT NK cells, as 
well as the potential for the reversal of the phenotype. The results described in this 
chapter indicate that NK cell licensing requires continued contact with MHC I molecules 
for its maintenance, and is reversible following loss of contact with MHC I, resulting in 
the induction of a hyporesponsive state. 
 
Introduction 
Upon initiation of this project, little was known regarding the plasticity of NK cell 
licensing. Questions as to whether licensing is a permanent phenotype, akin to lineage 
differentiation, or if it requires constant input to be maintained were not addressed at the 
time the licensing hypothesis was originally proposed [41]. However, while the 
permanency of the licensed phenotype had not been experimentally determined, 
extrapolation from published data led to predictions that NK cell licensing, once 
established, is permanent and fixed, with little to no potential for reversal. For example, 
many reports demonstrate that exposure of NK cells to MHC I-deficient targets results in 
NK cell activation and target cell cytolysis, not NK anergy [27, 28, 33, 35, 63, 106]. In a 
clinically relevant analogy, following bone marrow transplantation in the treatment of 
leukemic patients, it is reported that donor-derived NK cells can exert a beneficial anti-
tumor effect against residual host cells lacking normal surface expression of HLA alleles 
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[107-111]. Were the licensed phenotype easily reprogrammed or reversible, one might 
predict that contact with MHC I- or HLA-deficient cells would decrease NK cell 
responsiveness, not incite effector function as is observed. Therefore, these results 
support the idea that licensing is fixed. 
 
While experimental evidence generally did not substantiate the idea that licensing is 
reversible, our own results describing the gain of licensing by mature, MHC I-deficient 
NK cells following adoptive transfer to MHC I+ hosts led us to suspect that licensing 
might be more flexible than previously assumed. Therefore, we began a series of 
experiments to determine if licensing is reversible and which factors, if any, are 
necessary for the maintenance of the licensed phenotype.  
 
Loss of all contact with MHC I results in complete loss of NK cell function 
In order to examine the potential for loss of the licensed phenotype and effector functions 
conferred by licensing, splenocytes were purified from WT donors and adoptively 
transferred into β2m-/- recipients, or WT recipients as a control. At 7d post-transfer, host 
spleens were harvested and assessed for IFNγ production, via intracellular flow 
cytometry. When spontaneous cytokine production was examined, neither host nor donor 
NK cells were positive for IFNγ (Figure 23a). These results were initially surprising as, 
based on previously published data citing NK activation following exposure to MHC I-
deficient targets, we anticipated that WT NK cells might become activated in the β2m-/- 
hosts and demonstrate signs of activation upon harvest, such as spontaneous cytokine 
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production. However, our negative results clearly indicated that WT donor NK cells were 
not in a state of activation when recovered from MHC I-deficient hosts.  
 
Next, we conducted measurements of NK cell responsiveness to activation receptor 
cross-linking. We observed that WT donor NK cells recovered from β2m-/- hosts no 
longer responded normally to stimulation, making significantly less IFNγ than WT 
control NK cells (Figure 23b). In contrast, WT donor NK cells recovered from the control 
(WT) recipients produced a normal amount of IFNγ following stimulation, indicating that 
the decrease in cytokine production observed by WT cells recovered from β2m-/- hosts 
was not merely a consequence of adoptive transfer. These results demonstrated that WT 
NK cells recovered from MHC I-deficient hosts had specifically adopted a 
hyporesponsive phenotype. 
 
It remained possible that WT NK cells had become activated at time points early after 
transfer, and demonstrated low cytokine production in our assays as a result of 
‘exhaustion’, a phenomenon whereby chronic stimulation induces an anergic phenotype, 
best understood in the context of an antiviral T cell response [112, 113]. However, 
following stimulation with PMA (phorbol mistryl acetate) and ionomycin, agents which 
act on distal elements of intracellular signaling pathways [114], both WT donor as well as 
β2m-/- host NK cells retained the ability to produce large amounts of IFNγ (Figure 23c). 
Therefore, neither the lack of spontaneous IFNγ production by WT donor NK cells, nor 
their poor responses to receptor cross-linking could be explained by ‘exhaustion’. 
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Taken together, the results of these analyses indicate that following transfer to an 
environment devoid of MHC I expression WT NK cells appear to lose the potential for 
responsiveness and adopt a phenotype which corresponds to that of ‘unlicensed’ cells. 
 
Partial loss of contact with MHC I results in reduced, but not abrogated, function 
Although new data suggested that total loss of contact with MHC I could ‘unlicense’ WT 
NK cells, we considered an alternative explanation for the hyporesponsive phenotype 
displayed by WT NK cells recovered from β2m-/- hosts. We hypothesized that some 
minimal contact with MHC I might be necessary to maintain NK cell effector function in 
licensed cells, and that total loss of contact may completely disable a cell, resulting in a 
similar hyporesponsive phenotype as observed in unlicensed cells, but governed by a 
different mechanism. It could be possible that partial loss of NK cell inhibitory receptor 
contact with MHC I, for example following transfer to an environment lacking some but 
not all MHC I expression would not initiate the disabling program and would result in a 
different experimental outcome, such as activation of WT donor NK cells. 
 
Therefore, adoptive transfer experiments were devised to test the hypothesis that 
exposure to environments with expression of fewer MHC I alleles, as opposed to 
environments totally lacking MHC I expression, would result in activation of WT NK 
cells. Splenocytes from WT mice were purified and transferred to mice lacking 
expression of one MHC I allele, either H2Kb or H2Db (i.e. Kb-/-Db+ or Kb+Db-/-). At 7d 
post-transfer, host spleens were recovered and cytokine production assessed. Identical to 
results from transfer to MHC I-null environments, we found no spontaneous production 
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of IFNγ by either host or donor NK cells upon recovery from single-MHC I hosts. 
Following activation receptor cross-linking, WT NK cells recovered from single-MHC I 
hosts demonstrated low cytokine production, similar to that of their single-MHC I 
counterparts (Figure 24a). The functionality of single-MHC I NK cells is close to, but 
slightly better than, that of NK cells from mice completely lacking MHC I. It is 
interesting to note that the loss of the H2Kb allele appears to have a greater negative 
impact on functionality than does loss of the H2Db allele (Figure 24a). We hypothesize 
that this is due to greater licensing of C57BL/6 NK cells by H2Kb, which has been 
reported to be a better ligand for inhibitory receptors expressed in the C57BL/6 NKC 
[82]. Interestingly, following activation via PMA/ionomycin, it appears that there may be 
a slight defect in IFNγ production by donor WT NK cells recovered from single-MHC I 
hosts (Figure 24b). However, this result is not statistically significant. 
 
These results demonstrate that exposure of WT, licensed NK cells to environments 
expressing fewer MHC I alleles results in induction of a hyporesponsive phenotype, and 
is consistent with the idea that loss of contact with MHC I results in reversal of NK cell 
licensing. Additionally, these results, together with results from the transfer of WT NK 
cells to MHC I-deficient hosts, allow us to conclude that the loss of functionality appears 
gradated, with loss of contact with additional MHC I alleles resulting in greater loss of 
function. Assuming that loss of function operates analogously to gain of function, these 
data provide evidence that licensing does indeed appear to operate in the fashion of a 
rheostat, with a greater number of MHC I contacts resulting in an increase in the potential 
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for NK cell effector function, and fewer contacts resulting in decreased potential for 
function. 
 
Inhibitory receptor expression is only modestly increased on WT NK cells following 
loss of contact with MHC I  
Previously, we had demonstrated that the gain of function by β2m-/- NK cells following 
their transfer to MHC I+ hosts was accompanied by a specific decrease in inhibitory 
receptor expression for those receptors with an MHC I ligand expressed in the host  
(Figure 18). We therefore sought to determine if the inverse were also true: increase in 
inhibitory receptor expression (coincident with loss of function) following adoptive 
transfer of WT NK cells to MHC I-deficient hosts. 
 
To investigate the potential for increase in inhibitory receptor expression during loss of 
contact with MHC I (and loss of NK cell function), we performed adoptive transfer of 
WT NK cells to β2m-/- hosts and examined NK cell phenotype using flow cytometry. 
Upon harvest of host spleens at 7d post-AT, splenocytes were stained for surface 
markers, including inhibitory Ly49 receptor expression. Surprisingly, we found that the 
Ly49 inhibitory receptor expression on WT NK cells had increased only slightly 
following their transfer to MHC I-deficient hosts (Figure 25). The increased expression 
was still much lower than the expression of inhibitory receptors on the surface of MHC I-
deficient cells. Therefore, we may conclude that loss of function in WT NK cells 
following their adoptive transfer to MHC I-deficient environments can occur 
independently of a full increase in inhibitory receptor expression, suggesting that 
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inhibitory receptor surface expression may not be the (sole) mechanism governing NK 
cell function or licensing status.  
 
Change in MHC I-specificity or ‘relicensing’ of NK cells  
Having acquired data that supported the idea it is possible to reverse licensing in WT NK 
cells, we next questioned the flexibility of the MHC I-specificity in mature, licensed NK 
cells. New experiments were designed to explore the possibility that WT NK cells could 
become reprogrammed, or ‘re-licensed’, on MHC I alleles different from those on which 
they were originally licensed.  
 
Experiments to test the ability of WT NK cells to become re-licensed were initiated 
utilizing a system of adoptive transfer and MHC I-mismatch. Two genotypes of mice 
were used: C57BL/6 and B10.D2, which are congenic with C57Bl/6 mice, varying at the 
MHC I locus. Instead of expressing the H2b alleles H2Kb and H2Db as in C57BL6, 
B10.D2 mice express H2d alleles, H2Kd, H2Dd and H2Ld at the MHC I locus.  
 
Although in our previous experiments we had not directly addressed the presence of T 
cells in either host or donor splenocyte preparations, this series of experiments required 
greater consideration of such issues. It is known that in the absence of irradiation transfer 
of MHC I-disparate cell populations containing mature T cells can initiate an allospecific 
T cell response, leading to T cell activation and graft rejection, as well as widespread 
inflammation of the host [115, 116]. Therefore, in these experiments, donor NK cells 
were always sort-purified prior to transfer.  
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Sorted B10.D2 NK cells were transferred to Rag1-/- hosts (who are T cell deficient). (The 
inverse transfer could not be completed, as we lacked T cell-deficient B10.D2 hosts.) The 
results of these experiments showed that, even in the absence of alloreactive T cells, 
MHC I-disparate NK cells were eliminated (Figure 26). We hypothesize that this 
rejection may be due to the engagement of activating NK cell receptors with specificity 
for MHC I alleles, such as Ly49D [117, 118].  
 
Therefore, although conceptually interesting, this experimental system failed to provide 
interpretable results and we are currently unable to definitively conclude whether NK 
cells can become ‘relicensed’ on different MHC I alleles.  
 
MHC I expression is required on both hematopoietic and non-hematopoietic cells for 
maintenance of function 
Our results indicated that contact with MHC I is required in mature licensed NK cells in 
order to maintain their licensed state (Figure 22). Data utilizing bone marrow chimeras 
with restriction of MHC I expression to hematopoietic or non-hematopoietic 
compartments (described in Chapter 4) had shown that full MHC I expression in both 
compartments is necessary for the initial acquisition of the licensed phenotype. Using a 
similar system of bone marrow chimeras coupled with the technique of adoptive transfer, 
we determined that it would be possible to examine the importance of MHC I expression 
in these compartments for maintenance of the licensed phenotype.  
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Although one may initially predict that full MHC I expression is required in both 
compartments for maintenance of licensing as it is for acquisition of licensing, it is 
possible that the requirements for contact with MHC I are different in mature, licensed 
NK cells. There are other examples of differential requirement for contact with essential 
ligands depending on the maturation or activation status of the cell, particularly in the T 
and B cell lineages. For example, B cells become more dependent on signaling through 
the BLyS family receptors for survival as they mature [119]. In a converse example, 
memory T cells appear to become less dependent on contacts between TCR and MHC for 
survival and homeostatic proliferative capacity, opposed to their naïve counterparts [120-
122]. Additionally, it is possible that NK cells are licensed by one cell type, but are 
dependent on interactions with a different cell type for their maintenance in a licensed 
state. 
 
Therefore, to test the requirement for continued MHC I expression in hematopoietic and 
non-hematopoietic compartments in the maintenance of NK cell licensing, we performed 
adoptive transfer of WT NK cells to bone marrow chimeras, in which the hematopoietic 
or non-hematopoietic system lacked MHC I expression. We found that MHC I expression 
is required in both compartments to retain the licensed phenotype, as WT donor NK cells 
recovered from either chimera appeared hyporesponsive (Figure 27). Thus, the results 
indicated that MHC I is required in both compartments for maintenance of NK cell 
licensing and functional capacity, as it is required in both for initial acquisition of the 
licensed phenotype. 
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Conclusions 
Here we have investigated the potential for reversal of the licensed phenotype, as well as 
factors required for its maintenance. Experiments were conducted in which WT NK cells 
were transferred to hosts singly or totally deficient in MHC I and examined for their 
ability to produce IFNγ, spontaneously and following stimulation via activating receptor 
cross-linking or exposure to chemical stimulants. 
 
Results from the transfer of WT NK cells to MHC I-deficient hosts indicated that after a 
period of residence in an environment lacking MHC I expression, WT NK cells 
demonstrated a hyporesponsive phenotype, identical to that of unlicensed NK cells. 
Additionally, following adoptive transfer of WT to single MHC I-expressing hosts (either 
Kb-/- or Db-/-), WT cells acquire the (hyporesponsive) phenotype of the host environment. 
These data suggest that, contrary to previous assumptions, NK licensing is reversible and 
can be lost if contact with MHC I is disrupted. Additionally, we believe these results 
suggest that the rheostat model is that which best describes the licensing process, as there 
is a quantized loss of function upon sequential loss of MHC I contact.  
 
Previously, we had demonstrated that transfer of β2m-/- NK cells to MHC I+ hosts 
resulted in a gain of function in the in MHC I-deficient donor cells, as well as a decrease 
in the expression of inhibitory receptors specific for MHC I molecules expressed in the 
host environment. We hypothesized that this decrease in inhibitory receptor expression 
may be related to the gain of function, and might even be an underlying mechanism. 
Forming a complementary hypothesis, we then predicted that if inhibitory receptor 
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expression were inversely related to NK cell function, we would observe an increase in 
inhibitory receptor expression on the surface of WT NK cells following their transfer to 
MHC I-deficient hosts, corresponding to the observed loss of function. However, to our 
surprise, we did not find this to be completely true. WT NK cells recovered from β2m-/- 
hosts demonstrated only a partial increase in inhibitory receptor expression. These results 
suggest that surface expression of inhibitory receptors alone may be insufficient to 
regulate the functional phenotype of the host. Alternatively, the results may suggest that 
WT loss of function could be governed by a mechanism different from that which 
controls hyporesponsiveness in β2m-/- NK cells, or that the threshold for receptor 
calibration is much narrower than previously anticipated. 
 
Attempts to define the capacity of NK cells to become ‘relicensed’ on different MHC I 
alleles were unsuccessful. Perhaps they may be attempted in a host lacking cytotoxic 
capacity, such as the Jinx mouse, in order to preserve the grafted cells. Experiments 
probing the requirements for MHC I expression in maintenance of the licensed phenotype 
demonstrate that MHC I expression must be maintained in both hematopoietic as well as 
non-hematopoietic compartments in order for NK cells to remain functional. These 
results have interesting implications for the ideas of NK cell tolerance, as well as for 
implications of NK function in settings of chronic MHC I deficiency, such as the tumor 
microenvironment.  
 
Additionally, these data provide potentially important information regarding the necessity 
and sufficiency of trans and cis binding in establishment and maintenance of the licensed 
phenotype. Adoptive transfer of WT NK cells to β2m-/- hosts resulted in loss of WT NK 
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cell function, demonstrating that interactions with MHC I in trans are necessary to 
maintain the licensed phenotype. This experiment also demonstrates that cis interactions 
are insufficient to maintain WT NK cells in a licensed state. Also, previous experiments 
in which β2m-/- NK cells displayed increased function following transfer to WT hosts 
demonstrate that cis interactions are not necessary to induce licensing, and trans 
interactions are sufficient. Therefore a complete conclusion is that trans interactions are 
both necessary and sufficient to induce and maintain licensing, while cis interactions are 
neither necessary nor sufficient. 
 
Interestingly, we often noted that recovery of WT NK cells from MHC I-deficient hosts 
was relatively poor, compared to recovery from WT hosts. Co-identification of WT donor 
cells via CFSE-label and staining for a congenic marker (Ly5.1) did not reveal 
proliferation in the WT donor cell population, suggesting the cells were not ‘lost’ due to 
label dilution after division. We hypothesize that perhaps once licensed, there is a role for 
contact with MHC I in NK cell survival. As mentioned previously, data demonstrating 
dependence on contact with MHC I for survival has been presented for other immune 
subsets. Further experiments to investigate this hypothesis could involve examination of 
WT donor cells for surface markers of apoptosis upon recovery from MHC I-deficient 
hosts. If found to be elevated, perhaps mice deficient in components of the apoptotic 
pathway, or mice with transgenic expression of anti-apoptotic molecules (such as Bcl-2), 
could be used as the source of donor NK cells. In an alternative, though not mutually 
exclusive hypothesis, WT NK cells may be differentially localized following injection 
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into MHC I-deficient hosts. Extensive tissue distribution analyses were not performed 
and further investigation into this issue may prove interesting. 
 
Our results appear to indicate that NK cells may transition between functional and non-
functional states. In the next chapter, the biological relevance of this flexibility is 
investigated, with an examination of the in vivo relevance of free transition between 
licensed and unlicensed states. 
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Figure 23. WT NK cells are not activated and adopt a hyporesponsive phenotype 
following transfer to MHC I-deficient hosts. 
WT splenocytes were CFSE-labeled and adoptively transferred to β2m-/- hosts. At 7d 
post-transfer, NK cell production of IFNγ was assessed via intracellular flow cytometry. 
(a) Spontaneous IFNγ production by host and donor NK cells (gated on CD3-
NKp46+CFSE+/-), after 8hr ex vivo culture in normal medium. (b) IFNγ production by 
WT donor and β2m-/- host NK cells following anti-NK1.1 activation. (c) IFNγ production 
after treatment with PMA and ionomycin. Data are representative from 2 independent 
experiments, with 1-3 mice/group. 
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Figure 24. WT NK cells display a graded loss of function following transfer to hosts 
expressing a single MHC I allele. 
WT splenocytes were CFSE-labeled and adoptively transferred to hosts expressing a 
single MHC I allele. NK cell production of IFNγ was assessed 7d post-transfer via 
intracellular flow cytometry. (a) IFNγ production by WT donor and single MHC I host 
NK cells (CD3-NKp46+CFSE+/-) following 8hr ex vivo anti-NK1.1 activation. (b) IFNγ 
production after treatment with PMA and ionomycin. Data are pooled from 2 
independent experiments, with 2-4 mice/group for experimental and 1-2 mice/group for 
controls. 
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Figure 25. Inhibitory receptor expression on WT NK cells does not match level on 
MHC I-deficient NK cells following transfer to MHC I-deficient hosts. 
WT splenocytes were CFSE-labeled and adoptively transferred to β2m-/- hosts, then 
recovered 7d post-transfer. Inhibitory receptor surface expression on WT donor and   
β2m-/- host NK cells (CD3-NKp46+CFSE+/-) was quantified by antibody surface staining 
and flow cytometry. Data are representative of 4 independent experiments, with each dot 
representing a single spleen. 
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Figure 26. MHC I mismatched grafts are eliminated, in a T-independent manner. 
NK cells were sort-purified from B10.D2 splenocytes, CFSE-labeled and adoptively 
transferred to C57Bl/6 Rag1-/- or B10.D2 recipients. At 7d post-transfer, host spleens 
were harvested and analyzed for the presence of CFSE+ donor NK cells remaining. 
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Figure 27. MHC I expression is required in both hematopoietic and non-
hematopoietic compartments for maintenance of licensing. 
Bone marrow chimeras with varying hematopoietic and non-hematopoietic MHC I 
expression (as indicated) were generated. Chimeras were rested 8 – 10w, then given an 
adoptive transfer of CFSE-labeled WT splenocytes. Host spleens were recovered 7d post-
transfer and splenocytes were stimulated via anti-NK1.1 treatment. WT donor NK cells 
and host NK cells (containing a mixture of WT and β2m-/- cells) were assessed for IFNγ 
production via intracellular flow cytometry. 
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To more fully explore the contributions of MHC I density and localization to the 
generation and maintenance of functional NK cells, as well as to study the potential for 
unique patterns of NK cell distribution given simultaneous access to different 
environments, we created an experimental system utilizing parabiosis of mice differing in 
their expression of MHC I. These experiments indicate that parabiosis of MHC I-
deficient mice to WT partners is fundamentally and specifically detrimental to the MHC 
I-deficient partner, resulting in the induction of a syndrome with symptoms such as 
weight loss and extreme splenic atrophy, and resulting in death of parabionts 14 – 21 
days post-surgery. This phenotype appears to be at least partially NK-dependent, 
although there may be a role for T and B lymphocytes, as well. Interestingly, in MHC I-
deficient:WT pairs, unequal lymphocytic chimerism was consistently observed, with 
efficient engraftment of MHC I-deficient cells in WT partners, but very poor engraftment 
of WT cells in MHC I-deficient partners. These results provide new insight into the 
flexibility of NK cell licensing and the biological relevance of this property, in vivo. 
 
Introduction 
While adoptive transfer has proven a useful tool for studying acquisition and maintenance 
of NK cell function, this experimental system does have limitations. In particular, 
inherent restrictions on the number of donor NK cells able to successfully engraft in an 
unconditioned host environment limit the number and types of post-transfer analyses that 
may be performed on donor cells. Additionally, during preparation of the donor cell 
population, unintentional selection effects may occur. Furthermore, enforced localization 
of transferred cells by the chosen route of administration (i.v. injection) may artificially 
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dictate the final distribution of donor cells. Finally, when studying the behavior or 
functions of cells following their transfer to genetically deficient hosts, potentially 
unknown effects of the genetic deficiency on other cell types within the environment may 
lead to misinterpretation of results.  
 
In light of these potential difficulties associated with the use of adoptive transfer, we 
sought an alternative experimental system in which to accomplish lymphocyte exchange. 
One such system is that of parabiosis, or shared circulation. Historically, parabiosis has 
been used within the field of immunology to study immunological tolerance [123, 124] 
and immune cell trafficking [125-127], as well as in the study of physiological processes 
like metabolism [128]. With a relatively simple surgical technique, parabiotic animals are 
generated via connection of complementary surgical incisions. Vascular anastomosis is 
achieved as the incisions heal, resulting in a shared circulatory system and, theoretically, 
free and unlimited exchange of all blood components, including lymphocytes [125, 129]. 
Therefore, parabiosis appeared to meet our requirements for a new experimental system 
in which to study the flexibility of NK cell licensing, without the use of adoptive transfer. 
 
Parabiosis surgical protocol 
A protocol permitting the generation of and experimentation with parabiotic mice was 
drafted and was approved by the Washington University animal studies committee. 
Utilizing training obtained under the supervision of post-doctoral fellows in the 
laboratory of Dr. Michel Nussensweig (Rockefeller University), I established an 
experimental procedure of parabiosis in our lab. Briefly, female mice, 8-16w (average 
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12w), were surgically joined using 3 dissolvable sutures (two discontinuous sutures, one 
around each tibia and one around each ulna, as well as one continuous suture between the 
patellar ligaments) and approximately 15-20 wound clips (9mm stainless steel), located 
dorsally and ventrally along the entire length of the incision. Animals were supplied 
accessible gel nutrition for 2 weeks post-SX and were maintained on antibiotic drinking 
water from days -1 thru sacrifice. 
 
Gross external pathology reveals specific illness of β2m-/- when parabiosed to WT 
There were few outward differences in the appearance of β2m-/- and WT mice during days 
1 – 14 post-SX. However, between days 14 – 21 post-SX, β2m-/- mice parabiosed to WT 
partners begin to appear very ill, adopting a hunched posture and ruffled fur (Figure 28). 
Individual weights were taken before the surgical procedure and at the time of sacrifice. 
At weeks 1-2 post-SX, all mice appeared to lose some weight, typically less than 20% of 
body weight (on average around 10%), possibly due to factors such as dehydration and 
decreased food consumption. At times past 2w post-SX, β2m-/- mice parabiosed to WT 
partners appeared to rapidly lose a significant amount of weight (Figure 29a). However, 
total weight loss was difficult to determine definitively, as the pairs often died suddenly 
between weeks 2 and 3 post-SX, precluding a quantitative assessment. Co-housing of 
β2m-/- and WT mice in the absence of surgical joining did not induce weight loss, 
indicating that the mechanism of weight loss is unlikely related to infection or 
transmission of endogenous microbiota (Figure 29b). At no time were skin lesions or 
sores noticed on the tails or ears of any of the mice, as is commonly noted in settings of 
acute and chronic GVHD (graft vs. host disease) [130]. 
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Necropsy results do not readily reveal mechanism of illness in β2m-/- mice parabiosed to 
WT partners  
Six pairs of mice (β2m-/-:WT and WT:WT at 1, 2 and 3w post-SX) were submitted for 
necropsy to Dr. Suellen Greco, D.V.M. (Washington University, Division of 
Comparative Medicine). She examined gross anatomy, hydration and hematology, as 
well as histopathology of major organ systems, including: brain, heart, spleen, kidney, 
liver, lung, and intestines. No major cellular infiltration was noted in any organ of any of 
the experimental animals. Negative histopathology was later independently confirmed by 
Dr. Thad Stappenbeck. Although abscesses were often noted at the points of attachment 
(knees, elbows), all attempts to culture bacteria from these sites, as well as organs (heart, 
spleen, lymph nodes) were negative. PCR analyses of fecal pellets showed the animals to 
be negative for most pathogens tested, including: Citrobacter rodentium, Clostridium 
piliforme, Klebsiella oxytoca, Klebsiella pneumoniae, Mycoplasma pulmonis, 
Pneumocystis sp., Pseudomonas aeruginosa, Salmonella sp., Staph aureus, Shigella, 
Strep moniliformis, S. pneumoniae, Cryptosporidium, Giardia and pinworms. The 
animals did test positive for: MNV (murine norovirus), Helicobacter genus and Staph 
xylosus. However, these positive results are unlikely to account for the observed 
phenotype. 
 
Atrophy of MHC I-deficient spleen is the major pathological finding  
There were no gross differences noted in the lungs, kidneys, intestines, thymi or lymph 
nodes. Occasionally some livers, in both β2m-/- and WT mice when paired together, 
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appeared pale, suggesting anemia. This finding was not noted in control pairs (WT:WT, 
β2m-/-:β2m-/-). Additionally, there appeared to be a trend of cardiac atrophy in β2m-/- mice 
parabiosed to WT partners although, when normalized to body weight, the trend does not 
appear significant. The most striking, significant and reproducible finding upon gross 
internal examination was atrophy of the β2m-/- spleen, following parabiosis to a WT 
partner. 
 
When analyzed at 2w post-SX, the β2m-/- spleen in β2m-/-:WT pairs consistently appeared 
dramatically atrophied (Figure 30a). Cell counts confirm a decrease in cellularity, with 
changes evident as early as 1w post-SX (Figure 30b). By 3w post-SX, the β2m-/- spleen is 
almost completely acellular, with cell counts averaging less than 1×106 splenocytes. In 
β2m-/-:WT pairs, no increase in cellularity of the WT spleen was noted at any time point, 
suggesting that the decrease in cellularity of the β2m-/- spleen is not simply due to 
trafficking to and accumulation of β2m-/- cells in the WT partner. There is a slight 
decrease in cellularity of both spleens from control pairs, and we hypothesize this may be 
due to emigration of immune cells during the inflammation and healing processes 
following the surgical procedure.  
 
Increased cell death is one mechanism that could account for the decrease in cellularity of 
the β2m-/- spleen following parabiosis to a WT partner. Therefore, splenic apoptosis was 
evaluated by staining with AnnexinV (a protein that binds phosphotidylserine (PS) 
moieties, increased on the surface of cells during apoptosis) and 7-AAD (an intravital 
dye), followed by flow cytometry. We observed a measurable increase in apoptosis of 
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cells recovered from the β2m-/- spleen, indicating that the decrease in splenic cellularity 
may be due, at least in part, to increased β2m-/- splenocyte death after parabiosis to a WT 
partner (Figure 31). Interestingly, the increased apoptosis observed in β2m-/- splenocytes 
appears to be organ-specific. Cells from the bone marrow of mice in β2m-/-:WT pairs 
were harvested and similarly evaluated for apoptosis. However, no increase in apoptosis 
of bone marrow was observed for either parabiont, at any time 1-3w post-SX (Figure 31 
and data not shown). 
 
Splenic atrophy appears partially NK-dependent 
We next wished to determine if NK cells contributed to the striking atrophy of β2m-/- 
spleens following parabiosis to WT partners, possibly through mechanisms of 
degranulation or direct cytotoxicity. Preliminary experiments were conducted using two 
approaches: antibody-mediated depletion of NK cells, and a second approach of β2m-/- 
parabiosis to partners genetically deficient in immune cell components, including NK 
cells and T/B cells. With these experimental manipulations, we hoped to determine if NK 
cells are necessary and/or sufficient for the development of splenic atrophy, and if 
necessary, the mechanism by which they generate the phenotype. 
 
Antibody-mediated NK cell depletion was accomplished by injection of parabionts with 
anti-NK1.1 monoclonal antibody (PK136), once before surgery and at regular intervals 
(usually every 3-4d) until sacrifice. At 2w post-SX, we noted that some β2m-/- spleens 
from NK-depleted pairs appeared to retain cellularity equivalent to that of WT partners, 
implying that the destruction of the β2m-/- spleen is at least partially NK-dependent 
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(Figure 32). However, the number of β2m-/- which were ‘protected’ (3/9) did not appear 
to be much greater than the random number of β2m-/- mice which did not exhibit full 
splenic atrophy following parabiosis to WT partners, in the absence of NK-depletion 
(4/15). It is interesting to note the appearance of a bimodal distribution of splenic 
cellularity in β2m-/- spleens, following NK-depletion. Preliminary data do suggest that 
NK-depletion was not totally efficient in the parabionts, perhaps due to factors such as 
disruption in circulation or abnormal distribution of cells responsible for antibody-
mediated depletion, such as splenic macrophages. Further experiments examining 
antibody dosage and depletion efficiency are warranted. 
 
In a second method to discern NK contribution to β2m-/- splenic atrophy following 
parabiosis to WT partners, we generated new parabionts utilizing mice with known 
genetic deficiencies in immune cell components. For our first experiment, we hoped to 
join β2m-/- mice to MHC I+ mice deficient in NK cells. Unfortunately (until very recently 
with the discovery of E4bp4), truly NK-specific transcription factors have remained 
elusive. Therefore, currently there is no ‘NK knock-out’ mouse available. Other mouse 
models in which mature NK cells are not generated, such as the common signaling chain 
knock-out (γC-/-), have deficiencies in multiple immune cell lineages. Still other NK-
deficient models, such as IL-15-/-, lack components necessary for the generation and 
maintenance of NK cells and thus cannot support an exogenous (transferred) NK 
population. Therefore, in place of an NK cell knock-out mouse, we utilized NK-deficient 
mice (NKD strain, generated in the Yokoyama lab and described in [131]). Although 
these mice do posses immature NK precursors, they completely lack mature NK cells, a 
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phenotype attributed to a transgene insertion effect. Importantly, the immature precursor 
NK cells are not functional and these mice have documented defects in cytotoxicity. 
 
β2m-/-:NKD parabionts were generated and splenic cellularity was analyzed at 2w post-
SX. Interestingly, β2m-/- spleens did not appear significantly less cellular than their NKD 
counterparts (Figure 33a). However, parabiotic pairs utilizing NKD mice, both WT:NKD 
and β2m-/-:NKD, appeared less cellular overall. NKD mice have not been documented to 
have abnormal splenic cellularity, so the reason for this particular finding is unknown. 
The reduced cellularity of all parabionts in this series of experiments precludes definitive 
interpretation of these results. A more detailed examination of the normal cellularity in 
NKD mice, as well as NKD:NKD parabionts, would be of value. However, these 
preliminary results do suggest a role for mature WT NK cells in the manifestation of  
β2m-/- splenic atrophy, following parabiosis to WT partners. 
 
As preliminary data suggested a role for NK cells in β2m-/- splenic atrophy within 
parabiosis, we next wished to determine if NK cells are sufficient to induce this 
phenotype. To accomplish this, we produced parabionts by joining β2m-/- mice to mice 
deficient in Rag1, which lack both T and B cells. We hypothesized that if NK cells are 
sufficient to induce splenic atrophy in β2m-/- mice following parabiosis to WT partners, 
the atrophy phenotype would be reproduced in β2m-/- mice joined to Rag1-/-, as these 
partners maintain a mature and functional NK cell population. β2m-/-:Rag1-/- pairs were 
generated and splenic cellularity was determined at 2w post-SX. We found that in 
contrast to our predictions, β2m-/- mice did not display decreased splenic cellularity 
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following parabiosis to Rag1-/- partners (Figure 33b). In fact, β2m-/- splenic cellularity 
actually appeared increased, a novel finding within our experimental system.  
 
In the simplest interpretation, these results implicate a direct role for T and/or B cell 
function in β2m-/- splenic atrophy, following parabiosis to WT partners. However, it is 
important to note that detailed flow cytometry was not performed on these splenocytes. 
Therefore, it remains possible that the elevated gross cellularity of the β2m-/- spleen is 
achieved through a mechanism other than the preservation of β2m-/- splenocytes, such as 
increased colonization by Rag1-/- cells. Alternatively, perhaps the increase in cellularity is 
indeed accomplished via the preservation of endogenous β2m-/- splenocytes, and this 
result reflects an indirect role for T or B cells, through the support of proper WT NK cell 
function. Further work must be done to clarify this issue. Overall, these findings do 
suggest that NK cells alone are not sufficient to induce splenic atrophy in β2m-/- mice, 
following parabiosis to MHC I+ partners.  
 
Preliminary experiments utilizing mice genetically deficient in immune cell components 
revealed a necessary, though seemingly insufficient, role for NK cells in induction of 
splenic atrophy within parabiosis, but the mechanism for their action remained unclear. 
To examine the contribution of direct cytotoxicity to β2m-/- splenic atrophy within 
parabiosis, we utilized mice deficient in components necessary for degranulation, a 
process required for cytotoxic function. Jinx mice (previously described in Chapter 3, and 
in [55]) were parabiosed to β2m-/- mice, and splenic cellularity determined at 2w post-SX. 
Upon analysis, we found that β2m-/- mice had retained normal splenocyte counts (Figure 
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33c). Interestingly, we also noted that the spleens from Jinx mice parabiosed to β2m-/- 
partners appeared to be slightly more cellular than expected. It is proposed that direct 
cytotoxicity contributes to the resolution of the immune response, through elimination of 
activated lymphocytes, and we propose that the increase in cellularity of Jinx spleens may 
reflect an excess of activated immune cells, due to a defect in cytotoxic elimination of 
these cells.  
 
As all immune subsets in the Jinx mouse, including both NK and T cells, are disabled by 
the Jinx mutation, it is not possible to use this data to definitively discern the identity of 
the effector lymphocyte. However, the absence of β2m-/- splenic atrophy following 
parabiosis to Jinx mice does indicate that granule exocytosis, and resultant cytotoxicity, is 
likely to be a mechanism by which the atrophy is induced. 
 
Several different experimental techniques, including antibody mediated NK cell depletion 
as well as parabiosis to genetically deficient mice, were utilized to examine the role of 
NK cells in the induction of β2m-/- splenic atrophy, following parabiosis of these mice to 
WT partners. Although not entirely conclusive, NK depletion may point to a necessary 
role for NK cells. Parabiotic experiments with NKD mice appear to support this 
conclusion. Results from parabiosis of β2m-/- mice to Rag1-/- partners indicate that NK 
cells, while perhaps necessary, are not sufficient to induce splenic atrophy in MHC I-
deficient partners. Mechanistically, direct cytotoxicity appears to play an important role 
in the phenotype of splenic atrophy, as parabiosis of β2m-/- mice to partners defective in 
degranulation, and therefore cytotoxicity, did not result in the atrophy of β2m-/- spleens. 
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Overall, the role for NK cells in induction of splenic atrophy in MHC I-deficient mice 
appears complex and remains incompletely understood, but warrants further 
investigation, as it offers insight into fundamental processes governing NK cell tolerance. 
 
Unequal chimerism in spleen and blood of β2m-/-:WT parabionts 
Parabionts differing in their expression of the CD45 alleles (i.e. Ly5.1, Ly5.2) were 
generated and sacrificed at weeks 1-3 post-SX. Lymphoid chimerism, as well as NK-
specific chimerism of spleen, blood and bone marrow were established using antibody 
staining and flow cytometry. 
 
Analysis of lymphocytic chimerism in control pairs (WT:WT Ly5.1) revealed maximal 
splenic chimerism of around 40%, by about 1w post-SX (Figure 34a). The kinetics of this 
chimerism are faster than some previously published, which report maximal splenic 
chimerism at 3w post-SX [132]. In experimental pairs (β2m-/-:WT Ly5.1), β2m-/- 
lymphocytes achieve high levels of splenic chimerism in their WT partners, peaking at a 
maximal chimerism of around 50% (Figure 34a). In general, the kinetics of chimerism of 
MHC I-deficient cells in WT partners appear similar to the kinetics of chimerism 
observed in WT:WT Ly5.1 control pairs. 
 
Cellular composition of the β2m-/- lymphocyte population present in the WT spleen was 
evaluated by staining with antibodies specific for lineage-specific markers (e.g. CD3, 
CD4, CD8, CD19). Among β2m-/- lymphocytes, we found that each cell lineage was 
represented at approximately the same frequency as in the endogenous WT cell 
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population. When NK-specific chimerism was examined, we noted that β2m-/- NK cells 
appear to survive well in the WT partner, achieving an NK-specific chimerism of over 
50% by 2w post-SX (i.e., of all NK1.1+CD3- cells in the WT spleen at 2w post-SX, 50% 
are β2m-/--derived) (Figure 34b). From these data, we can conclude that establishment of 
β2m-/-chimerism in WT hosts is not due to an outgrowth of one MHC I-deficient cell type 
in particular, and that no single lymphoid lineage appears to possess a clear competitive 
advantage or disadvantage in colonization of the WT host. 
 
In contrast to the efficient chimerism of β2m-/- lymphocytes in WT spleens, we found that 
WT lymphocytes displayed poor chimerism in the spleens of their β2m-/- partners, 
reaching a maximum of less than 20% at 2w post-SX (Figure 34a). NK-specific 
chimerism of WT cells in β2m-/- hosts is particularly poor, with a maximum of less than 
15% at 2w post-SX (Figure 34b). It is possible that the decreased cellularity of the β2m-/- 
spleen following parabiosis to a WT partner does not allow for the normal chimerism of 
WT cells in β2m-/- hosts. However, the mechanism for the decreased chimerism of WT 
lymphocytes in the MHC I-deficient spleen remains unclear.  
 
Blood chimerism of parabionts was similarly evaluated. Unlike splenic chimerism, in 
which WT lymphocytes appeared with low frequency in their β2m-/- partners, WT and 
β2m-/- lymphoid chimerism of blood appeared more similar in both directions, ranging 
from 30 to 40% (Figure 35a), although there was considerable variability. Interestingly, 
although WT lymphocytes as a whole appeared to be well-represented in the blood of 
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both partners, WT NK cells were notably absent from β2m-/- blood, achieving chimerism 
of less than 10% (Figure 35b).  
 
A simple mechanism of exclusion could account for the deficiency of WT NK cells in 
β2m-/- partners, and would be predicted to result in an accumulation of WT NK cells 
within the WT host. However, spleens of WT mice parabiosed to β2m-/- partners 
contained normal absolute numbers of NK cells (Figure 35c), and blood from WT 
partners was not demonstrated to be enriched for NK cells (Figure 35d). These results 
suggest that simple exclusion of WT NK cells from the β2m-/- partner does not best 
describe why WT NK cells are found at low numbers in the β2m-/- partner. Instead, 
perhaps WT NK cells are displaced to an organ not yet examined, or experiencing 
disrupted homeostasis due to accelerated death or decreased production. 
 
In addition to examining splenic and blood chimerism, we also evaluated parabiotic bone 
marrow chimerism. We found that in contrast to the appreciable lymphoid chimerism 
observed in blood and spleen, chimerism of bone marrow in WT:WT Ly5.1 control pairs 
is very low (Figure 35e). Although we occasionally noted slightly increased chimerism in 
the bone marrow of β2m-/- mice from β2m-/-:WT experimental pairs (Figure 35e), there 
was very little difference in the percentage of NK cells within the bone marrow (Figure 
35f), indicating that the small increase in chimerism is not due to an NK-specific 
infiltration. The small number of mature NK cells that could be recovered from bone 
marrow were analyzed for surface expression of phenotypic markers of activation, such 
as CD69 and CD11b, but no major differences were observed. Additionally, Dr. Jeff Klco 
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(Washington University), confirmed normal marrow histology, including precursor 
frequency, in parabionts. 
 
NK cell licensing appears intermediate in parabionts 
Murine parabiosis was proposed in the context of this thesis work as an experimental 
method for manipulating the exposure of NK cells to elements required for licensing, 
specifically MHC I. Chimerism data demonstrated the presence of partner-derived NK 
cells in the spleen of each parabiont confirming that, through circulation of the cells to a 
new host, parabiosis results in an alteration of NK cell exposure to MHC I. We next 
wished to determine the effect of residence in the new environment on the licensing 
status of these immigrant NK cells. 
 
In order to determine the basal activation status of NK cells recovered from the 
parabionts, splenic NK cells from each parabiont were assessed for spontaneous IFNγ 
production. In all cases, no spontaneous IFNγ production was observed in NK cells from 
either parabiont, in either spleen (Figure 36a). Additionally, flow cytometry revealed no 
difference in surface expression of activation markers, such as CD69. These results 
indicate that within the setting of parabiosis, NK cells do not become activated upon 
exposure to an environment differing in MHC I expression. These data agree with results 
obtained within the adoptive transfer experimental system, as neither WT NK cells 
transferred to β2m-/- hosts nor β2m-/- NK cells transferred to WT hosts demonstrated 
spontaneous cytokine production, nor increased surface expression of activation markers. 
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Next, we measured IFNγ production following receptor cross-linking, in order to 
determine the NK cell licensing status. With the exception of β2m-/- NK cells recovered 
from the β2m-/- spleen, we found that all NK cells in both hosts from β2m-/-:WT pairs 
appeared to have an intermediate licensing phenotype (Figure 36b). This phenotype is 
reminiscent of that from mixed bone marrow chimeras (Chapter 4, Figure 22), lending 
further support to the hypothesis that NK cell function (licensing) is sensitive to the total 
amount of environmental MHC I, including that contributed by the hematopoietic 
compartment. The licensing status of NK cells from WT:WT control chimeras appeared 
normal, indicating that parabiosis alone does not impact NK cell functionality. 
 
Several possibilities may account for the variation observed in licensing status of β2m-/- 
NK cells recovered from the β2m-/- spleen, following parabiosis. It is possible that 
differential chimerism of microenvironments within the spleen may result in differential 
ability to promote NK cell licensing. Perhaps these NK cells, expected to become 
licensed but determined to have remained unlicensed, were sequestered by a large 
number of MHC I-deficient hematopoietic cells. In this case, it is possible that the β2m-/- 
cells could not make a sufficient number of contacts with MHC I on hematopoietic cells, 
and remained unlicensed. Splenic sectioning and staining for markers of origin (Ly5.1, 
Ly5.2) would be useful. 
 
Another potential explanation for the intermediate results of licensing in parabiotic NK 
cells may be attributed to time. Variation in NK cell residence time within each host 
could result in newly immigrated cells retaining normal or near normal function, while 
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cells with longer residence time are able to adopt the new phenotype. In support of this, 
kinetic analyses from adoptive transfer experiments clearly indicate that the gain of 
function of β2m-/- NK cells in WT hosts occurs at least 48hr after residence in the host. 
Therefore, it is possible that variation in our results is introduced by unsynchronized 
lymphocyte influx and efflux.  Unfortunately, although mechanisms exist for marking 
cells, such as BrdU (bromodexoyuridine) labeling, these labels are not useful for 
determining host-specific residence in a parabiotic system, as free diffusion allows 
dissemination of the label from one mouse to the other.  
 
Overall, we are able to state that NK cells do not appear activated within the parabiotic 
system, indicated by the absence of spontaneously produced cytokine. Additionally, we 
found that the licensing status of NK cells within MHC I-disparate parabionts is 
intermediate. 
 
Conclusions 
These experiments indicate that parabiosis of MHC I-deficient mice to WT mice results 
in decreased health of the MHC I-deficient partner. Severe splenic atrophy of the MHC I-
deficient partner was noted, with no corresponding increase in the cellularity of the 
spleen of the WT partner, suggesting that β2m-/- cells may be lost through a mechanism of 
death or relocalization, as opposed to emigration to or altered retention within the WT 
partner. 
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Parabiosis to genetically-deficient partners and antibody-mediated depletion studies point 
to a necessary, but insufficient role for NK cells in the induction of this splenic atrophy, 
likely through a mechanism of cytotoxicity. To further dissect the mechanism of splenic 
atrophy, experiments pairing β2m-/- mice to mice deficient in only T, B or NK cells (using 
mice such as Tcrα-/-, Igα-/- or E4bp4-/-) would be informative. Additionally, via 
generation of a novel mixed bone marrow chimera (Jinx marrow + Tcrα-/- into a WT 
host) and parabiosis of this chimera to a β2m-/- partner, it would be possible to examine an 
indirect role for T cell support of NK function. (This chimera would generate functional 
NK cells but only non-cytolytic T cells, so the influence of T cell presence on NK cell 
function could be assessed in the absence of cytotoxic T cell contributions.) Finally, it 
would be desirable to test the parabiosis of an NK-deficient, MHC I-deficient animal 
model (e.g. β2m-/- NKD or β2m-/-E4bp4-/-) to NK-deficient and –sufficient, MHC I+ 
partners, in order to evaluate the potential for pathogenesis by MHC I-deficient NK cells. 
 
Interestingly, we consistently observed that in β2m-/-:WT parabionts, chimerism of β2m-/- 
cells was efficient in WT partners, but chimerism of WT cells in β2m-/- hosts was lower 
than expected. The exact cause for this is unknown. However, it is documented that β2m-/- 
mice can develop a small population of functional CD8+ T cells, even in the absence of 
normal MHC I expression and proper positive and negative selection T cell selection 
[133, 134]. These cells have been documented to be highly reactive to antigenic peptides 
derived from MHC I [135]. Therefore, we hypothesize that the inefficient chimerism of 
WT cells into β2m-/- hosts may reflect the elimination of WT cells by anti-MHC I CD8+ T 
cells present in the β2m-/- partner. Although flow cytometry did not reveal a clear increase 
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in splenic or blood CD3+ or CD8+ lymphocytic populations, perhaps these actions occur 
locally, in tissues at the site of anastomosis. To test this hypothesis, one could attempt 
CD8+ T cell depletion in the context of β2m-/-:WT parabiosis, and look for increased 
chimerism of WT cells in the β2m-/- partner.  
 
The low level of chimerism observed in parabiotic marrow was somewhat surprising. We 
suspected that MHC I-deficient bone marrow cells may be particularly vulnerable to WT 
NK-mediated cytolysis, as β2m-/- bone marrow cells, even more so than β2m-/- 
splenocytes, are readily eliminated by WT NK cells. Perhaps the limited access of WT 
NK cells to β2m-/- bone marrow prevents the initiation of an immune response. 
Alternatively, WT NK cells may be tolerized to β2m-/- bone marrow, owing to their 
exposure to other β2m-/- cells, as is seen in the setting of adoptive transfer. 
 
Finally, results from functional assessments of parabiotic NK cells proved ambiguous. 
The licensing status of these cells is difficult to definitively determine, possibly due to 
uncoordinated movement of cells between hosts and differential residence times. To 
‘resynchronize’ NK cell populations, a survival surgery to separate parabionts could be 
performed, and splenic NK cell function analyzed at 3 or more days following separation. 
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Figure 28. MHC I-deficient mice parabiosed to WT partners appear unwell  
at 2w post-SX. 
Age-matched, 9 – 12 week-old female WT mice were parabiosed to (a) WT or (b) β2m-/- 
partners. At 2w post-SX, β2m-/- mice paired with WT partners (dorsal view, β2m-/- mouse 
is on right) display an overall unwell appearance, including hunched posture, flattened 
ears and ruffled fur. WT mice in the same pairs (dorsal view, left mouse), or in control 
pairs (WT:WT), demonstrate no obvious phenotype. Pictures depict 3 distinct pairs of 
mice and are representative of  >15 pairs, over multiple experiments. 
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Figure 29. Weight loss in parabiotic mice. 
Age-matched, 9 – 12 week-old female β2m-/-  mice were parabiosed to WT mice or β2m-/- 
(as control). (a) Individual weights were recorded at day -1 (before SX) and upon 
sacrifice and separation. The difference was calculated and is plotted as function of 
change in percent of initial weight, for times 1 – 3 weeks post-SX. Data are pooled from 
multiple experiments. Each dot represents a single mouse. (b) WT and β2m-/- mice were 
co-housed without surgical joining and weights were recorded. Data are from three pairs 
of mice, each pair housed in a separate cage. 
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Figure 30. Major splenic atrophy due to decrease in cellularity of MHC I-deficient 
spleen after parabiosis to WT. 
Age-matched, 9 – 12 week-old female WT mice were parabiosed to β2m-/- mice, or WT 
(as control). (a) Spleens harvested from parabionts at 2w post-SX. Pictures are 
equivalently scaled and representative of >15 pairs, over multiple experiments. (b) 
Splenic cellularity of parabionts was calculated at harvest, 1 – 3w post-SX. The blue and 
green lines represent β2m-/- and WT mice in a pair, while the black and grey lines 
represent WT mice paired with WT mice (as control). 
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Figure 31. Increased apoptosis in spleen, but not bone marrow, of MHC I-deficient 
partner after parabiosis to WT. 
Age-matched, 9 – 12 week-old female mice were joined in parabiotic pairs of β2m-/- :WT, 
β2m-/-:β2m-/- (control) and WT:WT (control). At 2w post-SX, spleens and bone marrow 
were recovered from each parabiont, stained with AnnexinV and 7-AAD, then analyzed 
via flow cytometry. Each dot represents one mouse and data are representative of 3 
independent experiments. 
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Figure 32. NK depletion in MHC I-disparate parabiotic mice. 
Age-matched, 9 – 12 week-old female WT mice were parabiosed to β2m-/- mice, or WT 
(as control). Mice in the NK-depleted group were injected i.p. with anti-NK1.1 
monoclonal antibody (PK136) at day -1 pre-SX and at regular intervals (every 3-4d) until 
sacrifice. Splenic cellularity of parabionts was calculated at harvest, 2w post-SX. Data 
are pooled from multiple experiments; each data point represents the spleen from one 
mouse. 
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Figure 33. Parabiosis of MHC I-deficient mice to partners with various genetic 
deficiencies to reveal mechanism of splenic atrophy. 
Age-matched, female β2m-/- mice were parabiosed to partners genetically deficient in 
various immune cell lineages and functions, including (a) NK-deficient (NKD), (b) T and 
B cell deficient (Rag1-/-), and (c) cytotoxicity-deficient (Jinx). Splenic cellularity was 
determined 2w post-SX. Splenic cellularity from β2m-/-:WT pairs (obtained in separate 
experiments) is included for reference. 
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Figure 34. Unequal splenic chimerism in MHC I-disparate parabionts. 
Parabiotic pairs of β2m-/-:WT Ly5.1 and WT:WT Ly5.1 were generated using age-
matched female mice. Splenic chimerism was determined by staining splenocytes for the 
differential CD45 allele. (a) Total lymphocytic chimerism (solid lines), and NK-specific 
chimerism, at times 1 – 3w post-SX. Data are pooled from multiple experiments, and 
each data point represents an average with 2-8 mice/point. (b) Individual representation 
of NK-specific splenic chimerism at 2w post-SX. Each dot represents an individual 
mouse. Data are pooled from 2 independent experiments. 
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Figure 35. Differential NK chimerism of blood but not bone marrow in MHC I-
disparate parabionts at 2w post-SX. 
Parabiotic pairs of β2m-/-:WT Ly5.1 and WT:WT Ly5.1 were generated using age-
matched female mice. Blood and marrow chimerism were determined by staining 
splenocytes for the differential CD45 allele, followed by flow cytometry. (a) Total 
lymphocytic chimerism of peripheral blood (obtained by cardiac puncture). (b) NK-
specific chimerism of peripheral blood. (c) Percentage of splenocytes identified as NK 
cells (CD3-NK1.1+). (d) Percentage of lymphocytes from peripheral blood identified as 
NK cells (CD3-NK1.1+). (e) Total lymphocytic chimerism of bone marrow. (e) 
Percentage of bone marrow identified as NK cells (CD3-NK1.1+). Data are pooled from 
multiple experiments; each data point represents an individual mouse. 
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Figure 36. NK cell licensing in parabionts. 
Parabiotic pairs of β2m-/-:WT Ly5.1 and WT:WT Ly5.1 were generated using age-
matched female mice. At 2w post-SX, spleens were harvested and NK cells stained for 
(a) spontaneous production of IFNγ and (b) production of IFNγ following NK1.1 
crosslinking. Data are from one experiment (a) or pooled from 2 independent 
experiments (b). Each point represents one mouse. 
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CHAPTER 7: 
Discussion 
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Major findings 
In this thesis work, we present several novel and interesting findings, which greatly 
advance our understanding of fundamental NK cell biology. The first of these findings is 
that MHC I-deficient NK cells can acquire normal function given access to MHC I, in a 
process which appears to be licensing. The capacity of MHC I-deficient NK cells to be 
influenced by a change in their environment disputes the idea that the signal responsible 
for licensing is cell-intrinsic, as has been previously proposed [74]. We conclude that the 
licensing signal is most likely not delivered in cis, and that engagement of NK inhibitory 
receptors by MHC I ligands presented in trans is sufficient to induce the licensed 
phenotype. Additionally, we find that there does not appear to be a critical window 
during development in which licensing must occur, perhaps further permitting the 
separation of licensing from the process of development.  
 
The second major finding of this work is that WT NK cells can be made hyporesponsive 
or ‘unlicensed’ following their transfer to environments devoid of MHC I expression. 
These results reveal that the licensed phenotype is not fixed, and further support the idea 
that licensing is dominated by contacts with MHC I in trans, as cis interactions alone are 
insufficient to maintain the licensed phenotype. 
 
Results from mixed bone marrow chimeras as well as from parabionts differing in MHC I 
expression reveal the potential for an intermediate functional phenotype of the NK cell 
population, refuting the longstanding theory of ‘dominant tolerance’ [56, 136]. Instead, 
we propose that all NK cells, regardless of intrinsic MHC I expression, are equally 
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sensitive to the amount of environmental MHC, and that these are the signals which 
regulate and maintain the responsiveness, or licensing, of an NK cell population. 
 
Advancements in theories on the mechanism of licensing 
While much progress has been made in understanding the role of MHC-specific receptors 
in NK cell education, there remain many unanswered questions. Primarily, the exact 
molecular mechanisms dictating licensing, including the identities of intracellular 
signaling molecules and their targets, remain unknown. We believe that our data may 
provide additional insight into the accuracy of some of the current theories regarding the 
mechanism of NK cell licensing. 
 
     Receptor ‘tuning’ 
In the theory of ‘receptor tuning’, it is postulated that NK cell responsiveness is 
influenced by the number of inhibitory receptors present at the NK cell surface (or by the 
access of these receptors to their ligands) [46, 48]. Following contact with an MHC I 
ligand, the surface expression level of inhibitory receptors is decreased (possibly via 
internalization). Expression of fewer inhibitory receptors translates to a decrease in the 
capacity to be inhibited, thus allowing NK cells to be more easily activated. This is the 
reasoning presented to explain the increased functionality (licensing) of NK cells from 
MHC I-expressing hosts. Incidentally, some researchers proposing that licensing occurs 
in the cis orientation have also supported the receptor tuning hypothesis. However, in 
their model the decreased MFI is explained by interactions between inhibitory NK cell 
receptors and their MHC I ligands, in cis. In any case, sequestration of inhibitory 
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receptors serves the same function as internalization would, which is to limit the capacity 
of receptors to contact their ligands, thereby limiting transmission of inhibitory signals 
and allowing for easier activation. 
 
Receptor tuning as the mechanism for NK cell licensing is an attractive theory for several 
reasons: experimentally, hypofunctional NK cells from MHC I-deficient hosts have been 
demonstrated to have high inhibitory receptor expression, while inhibitory receptor 
expression is documented to be lower on NK cells from hosts with expression of MHC I 
ligand, where NK cells are functional. Therefore, inhibitory receptor expression and NK 
cell functionality appear to be related. We reproduce these findings in our experiments, 
with the additional finding that gain of function in MHC I-deficient NK cells is 
accompanied by a corresponding decrease in cognate inhibitory receptor expression, 
again seeming to support the hypothesis that inhibitory receptor expression is related to 
functionality. Furthermore, in our in vitro experiments, simple mixing and co-culture of 
MHC I-deficient cells with WT cells was not shown to result in inhibitory receptor 
downregulation on MHC I-deficient cells, and these cells did not gain functional 
capacity, implying that a decrease in inhibitory receptor expression is necessary to 
acquire the gain in function. 
 
The theory of receptor tuning is also appealing as an explanation for the mechanism 
underpinning NK cell licensing, because it is allows for the reconciliation of inhibitory 
receptor function during licensing with traditional inhibitory receptor function. If 
signaling through the inhibitory receptor serves to remove it from the cell surface (or 
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sequester it), repeated contact with self MHC I ligands results in a net gain in NK cell 
functionality, through removal of a negative signal or influence (i.e., the double negative 
‘minus a minus’ results in a positive outcome).  
 
Although data exist to support receptor tuning as the mechanism for NK cell licensing, 
other data, including results of our own experiments, challenge this theory. The primary 
experimental piece of evidence that does not appear to completely agree with the theory 
of receptor tuning concerns inhibitory receptor expression on WT NK cells, following 
their transfer to MHC I-deficient hosts. In these studies, we noted that although WT cells 
lost functional capacity after transfer to MHC I-deficient hosts, their surface expression 
of inhibitory receptors only partially increased, to a level less than that expressed by 
MHC I-deficient NK cells. These results may be interpreted to mean: 1) the level of 
inhibitory receptor expression on MHC I-deficient NK cells is higher than the threshold 
necessary to interfere with activating signaling, or induce hyporesponsiveness, and/or, 2) 
another mechanism exists to induce hyporesponsiveness in WT NK cells, one which may 
be complementary to partial inhibitory receptor upregulation, or one which is unrelated; 
3) the changes in inhibitory receptor expression and NK cell functional capacity are true, 
true, and unrelated. 
 
To further explore the possibility of receptor tuning as a mechanism for NK cell 
licensing, I propose the creation of a mutant inhibitory receptor that cannot be 
internalized. This receptor cannot simply be a tailless mutant, as such a mutant would 
also lack the ITIM sequence, which has been demonstrated to be necessary for licensing 
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[41]. Instead, the receptor should be a deletion mutant, lacking other portions of the 
intracellular tail, or a mutant with sequence variation at regions outside of the ITIM. Our 
in vitro experiments indicate that, for unknown reasons, contact with MHC I in co-culture 
alone is insufficient for inhibitory receptor downregulation. Therefore, to test the ability 
of mutant receptors to downregulate following contact with MHC I, the mutants could be 
transfected into NK cells in vitro, then transferred to MHC I-expressing hosts. (As 
primary NK cells exhibit low transfection efficiency, a more realistic experiment would 
involve transfection into bone marrow and analysis of NK cells allowed to develop in 
bone marrow chimeras reconstituted with transfected bone marrow). Once a deficiency in 
internalization has been confirmed, the licensing status of these NK cells could be 
examined, in order to directly test the hypothesis that inhibitory receptor internalization is 
required to achieve licensing. 
 
In a final thought on receptor tuning as a mechanism for NK cell licensing, semantically, 
one must propose that unengaged receptors signal, or otherwise interfere with positive 
signaling. Otherwise, the high level of inhibitory receptor expression on MHC I-deficient 
NK cells would be of no consequence. In the next section, we will explore this idea in 
further detail, as we consider a second mechanism proposed to explain licensing. 
 
     Spatial reorganization of NK cell receptors 
Licensing appears to alleviate repression of signaling through multiple activating 
receptors, which utilize different signaling chains (i.e. NK1.1/FCRγ and Ly49H/Dap12, 
data presented in Chapter 3). This suggests that licensing may serve to act on a common 
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mechanism shared by all receptors, or that it operates at a point downstream where 
signaling for multiple activating receptors converges. However, although much effort has 
been expended, differential transcription of licensed and unlicensed cells has not been 
demonstrated, suggesting that licensing is not accomplished by transcriptional regulation 
of downstream signaling components, including kinases, phosphatases and transcription 
factors. This begs the question, “Is there a mechanism to generate disparity between two 
identical sets of items?” The answer is, yes: differential spatial organization. 
 
Recent work on NK cell inhibition (mostly by the Long group), demonstrates that 
inhibition likely does not function by a one-to-one dephosphorylation of activation 
receptors, but instead is accomplished through dephosphorylation of cytoskeletal 
components, necessary to reorganize and cluster activating receptors [26]. Theoretically, 
clustered activating receptors have more power to activate, due to factors such as 
transactivation and increased kinetic potential through greater probability of contact with 
downstream components, due to decreased travel through space. So, if inhibition works 
by preventing cytoskeletal rearrangements, perhaps licensing works by interfering with 
this inhibitory mechanism, and/or encouraging clustering of activating receptors, through 
a mechanism of exclusion. It is possible that transmembrane inhibitory receptors may 
achieve high density upon MHC I engagement, forcing activating receptors out, and 
together. Interestingly, this theory fits with the idea of receptor calibration by promoting 
a function for the presence of inhibitory receptors at the cell surface, without requiring 
these receptors to signal in the absence of ligand engagement. Recent literature reports 
describe what appears to be differential clustering of inhibitory and activating receptors at 
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the surface of licensed versus unlicensed NK cells [137], further lending credit to this 
theory as the mechanism by which NK cell licensing is achieved. Certainly, advances in 
this field of investigation will prove interesting. 
 
Physiological role of licensing 
While results from this thesis work further define parameters surrounding acquisition and 
retention of NK cell licensing, questions remain regarding its physiological function. 
Certainly it may be argued that the establishment of self-tolerance is a beneficial outcome 
of NK cell licensing, particularly in an immune lineage that does not appear to undergo 
deletion or receptor editing. However, recent publications challenge the notion that 
licensing is advantageous, citing the finding that licensed NK cells proliferate less and 
offer less protection in the context of viral infection [138]. 
 
We hypothesize that restraint in activation, a consequence of NK cell licensing, may 
better serve a real (non-experimental) host, where multiple pathogenic insults are 
encountered sequentially. If following infection there truly is a refractory period, perhaps 
the time required for generation of new NK cells, limits on NK cell activation imposed by 
licensing may prevent the induction of a temporary immunodeficiency. The idea that 
immunodeficiency arises following activation of the entire NK cell population may be 
experimentally tested: one could infect Ly49H Tg mice with MCMV and, at the phase in 
which activated NK cells contract, infect the mice with another pathogen (or conduct a 
tumor elimination challenge). It is likely that the previously infected Ly49H Tg mice will 
not fare well in the second challenge, compared to Tg mice not receiving a primary 
infection. Regardless of potential liabilities NK cell licensing may impart in the context 
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of infection, its beneficial functions of self-tolerance and self-recognition for the 
elimination of unhealthy cells are clearly recognized. 
 
Clinical relevance and applications  
Our data indicate that NK cell function with respect to host MHC environment is more 
plastic than originally anticipated, as in vivo exposure of a peripheral cell to the presence 
of an inhibitory ligand can alter the functional capacity of the NK cell. As such, these 
results may have important clinical implications. In particular, patients undergoing BM 
transplantation experience greater donor-mediated anti-leukemic effect when donor NK 
cells express KIRs specific for HLA lacking in the patient (reviewed in [108]). Therefore, 
within the context of the transfer of peripheral NK cells, such as NK immunotherapy, 
donor NK cells unlicensed by HLA alleles absent in the donor may become licensed by 
host HLA alleles, leading to a beneficial gain in reactivity of donor NK cells against host 
tumors lacking HLA expression. Perhaps prospective pairing of donor KIR along with 
donor and host HLA to anticipate gain of function by otherwise unlicensed donor NK 
cells may enhance patient outcomes.  
 
Additionally, our finding that NK cell licensing can be compromised following loss of 
contact with MHC I molecules holds potential for the use of NK cells in therapies to treat 
solid tumors. In our current understanding, NK cells have not been demonstrated to be 
particularly efficient at solid tumor elimination [139]. It is known that this is, at least in 
part, due to downregulation of activating receptors (particularly NKG2D), following 
contact with soluble activating ligands, shed from the tumor surface [140]. In addition to 
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ligand shedding as an immunoevasive strategy, tumors also demonstrate decreased 
expression of MHC I molecules. Perhaps NK cells are also rendered non-responsive to 
solid tumors because they become unlicensed in the local tumor microenvironment. 
Attempts to reestablish licensing could involve injection of single-chain MHC I 
molecules or cells transfected to express high levels of surface MHC I directly into the 
tumor. It is possible that the delivery of exogenous MHC I into the tumor may bolster NK 
cell anti-tumor activity to a level that would provide clinical benefit. Preliminary 
experiments are warranted.  
 
Concluding remarks 
Our data provide new insight into the flexibility of the licensing process, as we have 
shown that mature natural killer cells have the ability to become both licensed and 
unlicensed, depending on the expression of MHC I molecules in the host environment. 
Data demonstrating that expression of MHC I is required on hematopoietic and non-
hematopoietic cells, but not NK cells themselves, to produce and maintain the licensed 
phenotype reveal the correct physical orientation of the contact between these receptors 
and ligands during the licensing process. The findings of differential chimerism and 
phenotype in parabiosis of MHC I-deficient mice to WT partners suggest the presence of 
unappreciated factors that contribute to the maintenance of NK cell licensing, in vivo. 
Finally, we suggest that our results may translate to improvements in human NK cell 
therapies, particularly those for the treatment of hematological malignancies, with 
possibilities extending to treatment of solid tumors, as well. 
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